<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucsdsom_an_oapdeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent ucsdsom_an_oapdeposits items</title>
    <link>https://escholarship.org/uc/ucsdsom_an_oapdeposits/rss</link>
    <description>Recent eScholarship items from Department of Anesthesiology - Open Access Policy Deposits</description>
    <pubDate>Fri, 26 Jun 2026 21:34:08 +0000</pubDate>
    <item>
      <title>Effects of Noninvasive Cervical Vagal Nerve Stimulation on Cognitive Performance But Not Brain Activation in Healthy Adults</title>
      <link>https://escholarship.org/uc/item/5wf090r0</link>
      <description>OBJECTIVES: While preliminary evidence suggests that noninvasive vagal nerve stimulation (nVNS) may enhance cognition, to our knowledge, no study has directly assessed the effects of nVNS on brain function and cognitive performance in healthy individuals. The aim of this study was therefore to assess whether nVNS enhances complex visuospatial problem solving in a normative sample. Functional magnetic resonance imaging (fMRI) was used to examine underlying neural substrates.
MATERIAL AND METHODS: Participants received transcutaneous cervical nVNS (N&amp;nbsp;= 15) or sham (N&amp;nbsp;= 15) stimulation during a 3 T fMRI scan. Stimulation lasted for 2 min at 24 V for nVNS and at 4.5 V for sham. Subjects completed a matrix reasoning (MR) task in the scanner and a forced-choice recognition task outside the scanner. An analysis of variance (ANOVA) was used to assess group differences in cognitive performance. And linear mixed effects (LMEs) regression analysis was used to assess main and interaction...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5wf090r0</guid>
      <pubDate>Wed, 29 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Klaming, Ruth</name>
      </author>
      <author>
        <name>Simmons, Alan N</name>
        <uri>https://orcid.org/0000-0003-3963-2112</uri>
      </author>
      <author>
        <name>Spadoni, Andrea D</name>
      </author>
      <author>
        <name>Lerman, Imanuel</name>
        <uri>https://orcid.org/0000-0002-6564-7222</uri>
      </author>
    </item>
    <item>
      <title>Distinct effects of fibromyalgia pain, depression and anxiety on perception of affective touch and pain</title>
      <link>https://escholarship.org/uc/item/02q487sx</link>
      <description>Gentle stroking that activates C-tactile afferents is typically pleasant, calming and pain relieving. Deep pressure touch frequently elicits similar affective responses. However touch is often less pleasant for individuals with chronic pain. It is important to understand the reasons for this clinical difference because of the close relationship of pain with reduced social connection, and the widespread use of touch-based therapies for pain relief. It is not known whether differences in touch perception in chronic pain relate to pain-specific processes or to comorbid affective symptoms. The current study compared affective touch perception in adults with the chronic pain condition fibromyalgia (FM) and no-pain (NP) controls, and the contributions of pain, depression, anxiety and trauma history to differences in touch perception. We hypothesized that deep pressure - like gentle stroking - would be less pleasant in FM and that these differences would be associated with depression...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/02q487sx</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Albinni, Benedetta</name>
      </author>
      <author>
        <name>Zimmerman, Marisa</name>
      </author>
      <author>
        <name>Alasha, Vincent</name>
      </author>
      <author>
        <name>Ross, Jacob</name>
      </author>
      <author>
        <name>Crankshaw, Lindsey</name>
      </author>
      <author>
        <name>Hu, Sandy R</name>
      </author>
      <author>
        <name>Schuster, Nathaniel</name>
      </author>
      <author>
        <name>Case, Laura</name>
        <uri>https://orcid.org/0000-0003-3730-2451</uri>
      </author>
    </item>
    <item>
      <title>Accuracy and precision of minimally-invasive cardiac output monitoring in children: a systematic review and meta-analysis</title>
      <link>https://escholarship.org/uc/item/72v6w2gs</link>
      <description>Abstract
Several minimally-invasive technologies are available for cardiac output (CO) measurement in children, but the accuracy and precision of these devices have not yet been evaluated in a systematic review and meta-analysis. We conducted a comprehensive search of the medical literature in PubMed, Cochrane Library of Clinical Trials, Scopus, and Web of Science from its inception to June 2014 assessing the accuracy and precision of all minimally-invasive CO monitoring systems used in children when compared with CO monitoring reference methods. Pooled mean bias, standard deviation, and mean percentage error of included studies were calculated using a random-effects model. The inter-study heterogeneity was also assessed using an I2 statistic. A total of 20 studies (624 patients) were included. The overall random-effects pooled bias, and mean percentage error were 0.13&amp;nbsp;±&amp;nbsp;0.44&amp;nbsp;l&amp;nbsp;min−1 and 29.1&amp;nbsp;%, respectively. Significant inter-study heterogeneity was detected...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/72v6w2gs</guid>
      <pubDate>Thu, 26 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Suehiro, Koichi</name>
      </author>
      <author>
        <name>Joosten, Alexandre</name>
        <uri>https://orcid.org/0000-0002-5214-4589</uri>
      </author>
      <author>
        <name>Murphy, Linda Suk-Ling</name>
        <uri>https://orcid.org/0000-0003-2948-0792</uri>
      </author>
      <author>
        <name>Desebbe, Olivier</name>
      </author>
      <author>
        <name>Alexander, Brenton</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>Kim, Sang-Hyun</name>
      </author>
      <author>
        <name>Cannesson, Maxime</name>
      </author>
    </item>
    <item>
      <title>Expanding Access to Vascular Imaging: Preliminary Results from the Development of a Remote Surveillance Device</title>
      <link>https://escholarship.org/uc/item/0kj233w1</link>
      <description>Introduction/Objectives Patients undergoing surgical procedures for peripheral artery disease and carotid artery stenosis are recommended to undergo surveillance imaging at regular intervals. With &amp;gt; 250,000 patients undergoing interventions for both annually, the number of patients requiring interval surveillance increases in parallel, placing strain on an already overburdened health system. In this study we evaluated the performance of a novel ultrasound platform prototype built for remote ultrasound surveillance. Methods The prototype duplex ultrasound device was developed by a team of engineers and utilizes color flow images to detect the vessel for flow velocity measurements. The device was tested on 28 healthy volunteers. The results of spectral flow from the device were compared to standard of care ultrasound measurements of the CFA, SFA, ICA and CCA. Results The mean absolute difference between the prototype ultrasound and standard of care device for peak systolic velocity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0kj233w1</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Perez, Sean</name>
      </author>
      <author>
        <name>Lin, Muyang</name>
      </author>
      <author>
        <name>Zhou, Sai</name>
      </author>
      <author>
        <name>Walba, Lonnie</name>
      </author>
      <author>
        <name>Frederick, Destiny</name>
      </author>
      <author>
        <name>Kistler, Erik</name>
        <uri>https://orcid.org/0000-0002-6512-4798</uri>
      </author>
      <author>
        <name>Barleben, Andrew</name>
      </author>
      <author>
        <name>Malas, Mahmoud</name>
        <uri>https://orcid.org/0000-0002-2865-4079</uri>
      </author>
      <author>
        <name>Xu, Sheng</name>
      </author>
      <author>
        <name>Ross, Elsie G</name>
      </author>
    </item>
    <item>
      <title>Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis</title>
      <link>https://escholarship.org/uc/item/7p27h94g</link>
      <description>OBJECTIVE: Strategies are needed for patients with chronic pain who are using opioids to safely and effectively wean opioids without worsening of pain. The objective was to measure associations between medical cannabis authorization (MCA) and opioid milligram equivalents (OME) in patients with chronic non-cancer pain.
DESIGN: A longitudinal, retrospective cohort analysis from July 2016 to August 2019.
SETTING: Electronic health record data were analyzed.
SUBJECTS: Adult patients (≥18 years) seen in a university-based pain clinic.
METHODS: Longitudinal multilevel modeling with maximum likelihood estimation.
RESULTS: Average overall OME at the final time point was 33.4 mg/day (SE = 1.18) with increase over time of 0.45 mg/day per quarter (not statistically significant). Average OME in those without MCA was 32.60 mg/day (SE = 1.11) versus 38.51 mg/day (SE = 4.81) in those with MCA, not significantly different. Medical cannabis consultation predicted a nonsignificant decrease of 14.25 mg/day...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7p27h94g</guid>
      <pubDate>Thu, 29 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sexton, Michelle</name>
      </author>
      <author>
        <name>Glodosky, Nicholas C</name>
      </author>
      <author>
        <name>Cleveland, Michael</name>
      </author>
      <author>
        <name>Cuttler, Carrie</name>
      </author>
      <author>
        <name>Lee, Euyhyun</name>
      </author>
      <author>
        <name>Polston, Gregory R</name>
      </author>
      <author>
        <name>Furnish, Timothy</name>
        <uri>https://orcid.org/0000-0002-4615-3366</uri>
      </author>
      <author>
        <name>Lerman, Imanuel</name>
        <uri>https://orcid.org/0000-0002-6564-7222</uri>
      </author>
      <author>
        <name>Schuster, Nathaniel M</name>
      </author>
      <author>
        <name>Wallace, Mark S</name>
      </author>
    </item>
    <item>
      <title>Cannabis use disorder and mortality among patients with colon cancer</title>
      <link>https://escholarship.org/uc/item/8q65f6mh</link>
      <description>Cannabis use disorder and mortality among patients with colon cancer</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8q65f6mh</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Diabetes medications and dementia risk: Comparisons of SGLT2 inhibitors, GLP-1 RAs, metformin, and their combinations</title>
      <link>https://escholarship.org/uc/item/7r8337nw</link>
      <description>Background Type 2 diabetes (T2D) elevates dementia risk through vascular injury, neuroinflammation, and perturbed insulin signaling. Antidiabetic classes differ in extra-glycemic actions that could modify neurodegeneration, yet head-to-head comparative data remain limited. Objective To compare time to incident dementia among older adults with T2D exposed to SGLT2 inhibitors, GLP-1 receptor agonists (GLP-1 RAs), metformin, or two-way combinations, and to quantify the contribution of comorbidities and neuroactive co-medications. Methods We performed a retrospective cohort study in the UCHDW (2012–2024). Adults aged 55–80 were assigned to the earliest qualifying exposure group and followed from index to first coded Alzheimer’s disease or unspecified dementia; vascular/multi-infarct dementias were excluded by design to reduce etiologic heterogeneity. Events recorded within 84 days of index were not considered incident outcomes (individuals were retained and censored at 84 days). Covariates...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7r8337nw</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Nemeh, Gabrielle R</name>
      </author>
      <author>
        <name>Doede, Aubrey L</name>
      </author>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Influence of Substance Use Disorders on Mortality in a Systemwide Cohort of Cancer Patients</title>
      <link>https://escholarship.org/uc/item/7cm740kw</link>
      <description>BACKGROUND: Cancer treatment is often complicated by co-occurring substance dependence such as alcohol, cannabis, opioids, amphetamines, and tobacco. The objective of this study was to analyze the association between substance use (alcohol, cannabis, opioids, amphetamines, and tobacco) and mortality among cancer patients.
METHODS: This retrospective study used de-identified data from the University of California, San Diego Health on 22,763 cancer patients aged ≥&amp;nbsp;18&amp;nbsp;years. Substance dependance post-diagnosis was identified based on clinical observations from electronic health records. Tumor staging was determined using the TNM system, with missing data imputed via biomarker-based regression. Cox proportional hazards models were computed to assess severity-adjusted associations between substance dependance, by type, and mortality.
RESULTS: Cannabis dependence was not significantly associated with mortality. Alcohol, tobacco, opioid, and amphetamine dependence were linked...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7cm740kw</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Khoyilar, Shawnly</name>
      </author>
      <author>
        <name>Purushothaman, Vidya</name>
      </author>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>The Influence of GLP-1 Receptor Agonists on Five-Year Mortality in Colon Cancer Patients</title>
      <link>https://escholarship.org/uc/item/6k9803hf</link>
      <description>Colorectal cancer is a leading cause of morbidity and mortality worldwide. This study investigates the association between GLP-1 receptor agonists (GLP-1 RAs) and five-year mortality in patients with primary colon cancer, considering BMI. Using data from the University of California Health Data Warehouse, 6,871 patients were analyzed. Five-year mortality was 15.5% for GLP-1 RA users compared to 37.1% for non-users. Analyses showed significantly lower odds of five-year mortality with GLP-1 RA use (OR = 0.38, 95% CI: 0.21-0.64). This benefit persisted after adjusting for confounders, including disease severity, but was found to only extend to high obese patients (BMI &amp;gt; 35) in stratified modeling.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6k9803hf</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Cannabis use disorder and five-year risk of oral cancer in a multicenter clinical cohort</title>
      <link>https://escholarship.org/uc/item/38f1z8wp</link>
      <description>Objective: Cannabis use disorder (CUD) is increasingly prevalent in the United States, yet long-term health consequences remain poorly defined. Oral cancer is plausible given shared carcinogens between cannabis and tobacco. This study assessed associations between CUD and five-year oral cancer risk in a large clinical cohort.
Methods: This retrospective cohort study analyzed clinical records from the University of California Health Data Warehouse, covering six academic medical centers. Adults screened for drug use disorders between January 2012 and December 2019 were included if they had no prior oral cancer diagnosis. The index date was the date of first screening. Patients were followed for five years for oral cancer diagnoses (lip or tongue), thereby extending data collection to December 2024. CUD was defined by a new ICD-coded diagnosis during follow-up. Logistic regression and Cox proportional hazards models estimated odds ratios (ORs), hazard ratios (HRs), and 95&amp;nbsp;%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/38f1z8wp</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Mindfulness meditation reduces pain more effectively than slow-breathing meditation: the mediating role of respiration.</title>
      <link>https://escholarship.org/uc/item/3jk7x5cn</link>
      <description>ABSTRACT: Mindfulness meditation, a slow breathing practice that is predicated on cultivating nonreactive awareness, also reduces pain. The existing literature has been mixed in demonstrating whether mindfulness meditation is more effective than slow breathing alone (ie, sham-mindfulness meditation) at reducing pain. Furthermore, smaller sample sizes in prior work have hindered a clear understanding of how respiration rate and state anxiety contribute to analgesia during meditation. This study pooled data from 5 randomized controlled trials using paralleling interventions and methodologies in 245 healthy, pain-free, meditation-naïve individuals. Noxious heat (49°C; right calf) was used to test whether changes in respiration and state anxiety mediate the effects of (1) mindfulness meditation (n = 113), (2) a slow-breathing sham-mindfulness meditation technique (n = 73), and (3) a book-listening control (n = 60) on pain intensity ratings ("0" no pain; "10" worst pain imaginable)....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3jk7x5cn</guid>
      <pubDate>Mon, 10 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Amorim, Anita B</name>
      </author>
      <author>
        <name>Gianola, Morgan</name>
        <uri>https://orcid.org/0000-0002-6205-3015</uri>
      </author>
      <author>
        <name>Barrows, Daniel</name>
      </author>
      <author>
        <name>Zeidan, Fadel</name>
      </author>
    </item>
    <item>
      <title>Percutaneous analgesic device enabling both local anesthetic delivery and electrical stimulation (neuromodulation) of peripheral nerves: a pilot feasibility study (case series)</title>
      <link>https://escholarship.org/uc/item/1jv431x5</link>
      <description>BACKGROUND: A novel device integrating both local anesthetic delivery and peripheral nerve stimulation (PNS) to treat postoperative pain is under development. The device uses a catheter-over-needle design that permits ultrasound-guided percutaneous insertion. An integrated electrode and pulse generator enable PNS for up to 28 days. Such an approach may represent a paradigm shift in postoperative pain management by enabling the delivery of (1) a single-injection peripheral nerve block, (2) a continuous peripheral nerve block, and (3) neuromodulation-all through a single system that can be placed in a timeframe comparable with that of a traditional single-injection nerve block. The current prospective pilot study was executed under a US Food and Drug Investigational Device Exemption to develop insertion and management protocols, as well as assess the feasibility and safety of using the device to treat postoperative pain.
METHODS: Preoperatively, adults (n=20) undergoing moderate-to-severely...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1jv431x5</guid>
      <pubDate>Thu, 6 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Park, Brian H</name>
        <uri>https://orcid.org/0000-0003-2916-5696</uri>
      </author>
      <author>
        <name>Sinha, Sanjay K</name>
      </author>
      <author>
        <name>Leek, Bryan</name>
      </author>
      <author>
        <name>Meunier, Matthew J</name>
      </author>
      <author>
        <name>Foran, Ian M</name>
      </author>
      <author>
        <name>Hurvitz, Andrew</name>
      </author>
      <author>
        <name>Kent, William T</name>
      </author>
      <author>
        <name>Schwartz, Alexandra K</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>Alkabalan, Rafael</name>
      </author>
      <author>
        <name>Lau, Nathan</name>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
    </item>
    <item>
      <title>Cryoanalgesia to treat phantom limb pain following a trans-femoral (above-knee) amputation: a randomized, sham-controlled pilot study</title>
      <link>https://escholarship.org/uc/item/0145m226</link>
      <description>BACKGROUND: A previous clinical trial applied percutaneous cryoneurolysis to lower limb amputees with phantom pain. The primary outcome measure was negative, but a secondary analysis suggested that patients with a below-knee amputation (BKA) improved, while the opposite was true for above-knee amputations (AKA). We theorized two potential reasons for this difference: cryoneurolysis was inadequate for the larger sciatic nerve in the upper thigh for AKA versus the lower thigh for BKA; and BKA is innervated by only two nerves, both of which were treated while AKA involved two additional nerves left untreated.
METHODS: Participants with an existing AKA and intractable phantom pain had four nerves treated with ultrasound-guided percutaneous cryoneurolysis in the upper thigh: sciatic, femoral, obturator, lateral femoral cutaneous. For the larger nerves, we used an argon-based machine capable of inducing temperatures as low as -100°C and producing a relatively large ice ball. The sciatic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0145m226</guid>
      <pubDate>Thu, 23 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>Vadakkan, Sabeeca</name>
      </author>
      <author>
        <name>Alkabalan, Rafael A</name>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
    </item>
    <item>
      <title>A GI‐Interoceptive Threat Theory of Restrictive Eating: Insights From Active Inference and Chronic Pain</title>
      <link>https://escholarship.org/uc/item/1kw4k8qs</link>
      <description>INTRODUCTION: Restrictive eating is a common eating disorder (ED) behavior and risk factor. Disturbed body image is also highly associated with the development and maintenance of eating disorders. Yet body image often remains distorted after treatment, and there is little scientific understanding of the mechanisms by which restrictive eating and distorted body image are linked. In parallel, current models of chronic pain describe how fear and negative beliefs about pain lead to avoidance of painful sensations and a threatened response to their occurrence, entrenching a cycle of amplified pain that risks becoming chronic. These models are informed by theories of active inference, which describe how the brain actively shapes sensory experience to reduce prediction errors (discrepancy between predictions and sensory data). This understanding has led to significant advances in the treatment of chronic pain.
METHODS: Theories of active inference and central sensitization in chronic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1kw4k8qs</guid>
      <pubDate>Mon, 13 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Case, Laura</name>
        <uri>https://orcid.org/0000-0003-3730-2451</uri>
      </author>
    </item>
    <item>
      <title>Distinct somatic mutation profiles in colon cancer by behavioral comorbidity</title>
      <link>https://escholarship.org/uc/item/6x04x3gk</link>
      <description>BACKGROUND: Tobacco use, obesity, and type 2 diabetes are risk factors for colorectal cancer, but whether they generate distinct tumor mutation patterns is unclear. Tobacco is a known mutagen, while obesity and diabetes may act through metabolic and inflammatory pathways.
METHODS: We analyzed colon cancer patients from the University of California Health Data Warehouse, linking clinical sequencing data to diagnosis-based indicators of tobacco dependence, obesity, and type 2 diabetes. For each gene-behavior pair, we conducted reverse logistic regressions and calculated a combined score reflecting the strength and specificity of association adjusting for demographic covariates and cancer stage. Multidimensional scaling and clustering assessed behavioral differentiation.
RESULTS: Of 981 gene-behavior tests, 87 pairs exhibited a behavioral association at &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001 in adjusted models. Of these, 60 tobacco, 12 obesity, and 9 diabetes pairs had affinity ≥0.5; 48 tobacco pairs...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6x04x3gk</guid>
      <pubDate>Thu, 25 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Assessing the impact of environmental tobacco smoke on five-year cancer mortality</title>
      <link>https://escholarship.org/uc/item/38d93708</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Environmental tobacco smoke (ETS), also known as passive smoke, is a major public health concern due to its adverse health effects, which are comparable to those of active smoking. Although the risks of ETS for cardiovascular and respiratory outcomes are well documented, less is known about its impact on cancer prognosis. This study evaluated the association between ETS exposure and five-year all-cause mortality among patients diagnosed with breast, colorectal, lung, melanoma, or stomach cancer.&lt;h4&gt;Methods&lt;/h4&gt;Clinical data were obtained from the UC San Diego Health system and the UC Health Data Warehouse. The study cohort included 17,729 adult patients with a confirmed cancer diagnosis and no recorded history of active smoking. ETS exposure and five-year mortality were identified using structured electronic health record data. Multivariable exact logistic regression and Cox proportional hazards models were used to estimate the association between ETS exposure...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/38d93708</guid>
      <pubDate>Thu, 25 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Liu, Jiarong</name>
      </author>
      <author>
        <name>Purushothaman, Vidya</name>
      </author>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Effect of warm pressure on feelings of social connection with close others</title>
      <link>https://escholarship.org/uc/item/5fq9m463</link>
      <description>Social touch, such as hugging and hand-holding, may aid in the maintenance of feelings of social connection. Research on gentle stroking has demonstrated its social-affective effects. However, other elements of touch that might contribute to feelings of social connection are poorly understood. The current research seeks to determine the effect of warmth and pressure, given their involvement in social touch, on feelings of social connection with close others. In a 2 × 2 within-subjects experiment, 75 participants (M age = 19.89, 77.30 % women), were exposed to repeated trials of warm or neutral temperature packs, combined with deep or light pressure from weighted blankets, while they viewed images of close others. Feelings of social connection towards the pictured individuals were collected after each trial. After adjusting for age, there was an interaction such that warm deep pressure increased feelings of social connection compared to warm light pressure and neutral deep pressure....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5fq9m463</guid>
      <pubDate>Tue, 16 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Damon, Zoe F</name>
      </author>
      <author>
        <name>Kathman, Grace M</name>
      </author>
      <author>
        <name>Case, Laura K</name>
        <uri>https://orcid.org/0000-0003-3730-2451</uri>
      </author>
      <author>
        <name>Inagaki, Tristen K</name>
      </author>
    </item>
    <item>
      <title>Accuracy and precision of non-invasive cardiac output monitoring devices in perioperative medicine: a systematic review and meta-analysis † † This Article is accompanied by Editorial Aew442.</title>
      <link>https://escholarship.org/uc/item/5500w1pd</link>
      <description>Cardiac output (CO) measurement is crucial for the guidance of therapeutic decisions in critically ill and high-risk surgical patients. Newly developed completely non-invasive CO technologies are commercially available; however, their accuracy and precision have not recently been evaluated in a meta-analysis. We conducted a systematic search using PubMed, Cochrane Library of Clinical Trials, Scopus, and Web of Science to review published data comparing CO measured by bolus thermodilution with commercially available non-invasive technologies including pulse wave transit time, non-invasive pulse contour analysis, thoracic electrical bioimpedance/bioreactance, and CO2 rebreathing. The non-invasive CO technology was considered acceptable if the pooled estimate of percentage error was &amp;lt;30%, as previously recommended. Using a random-effects model, sd, pooled mean bias, and mean percentage error were calculated. An I2 statistic was also used to evaluate the inter-study heterogeneity....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5500w1pd</guid>
      <pubDate>Tue, 2 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Joosten, A</name>
        <uri>https://orcid.org/0000-0002-5214-4589</uri>
      </author>
      <author>
        <name>Desebbe, O</name>
      </author>
      <author>
        <name>Suehiro, K</name>
      </author>
      <author>
        <name>Murphy, LS-L</name>
        <uri>https://orcid.org/0000-0003-2948-0792</uri>
      </author>
      <author>
        <name>Essiet, M</name>
      </author>
      <author>
        <name>Alexander, B</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>Fischer, M-O</name>
      </author>
      <author>
        <name>Barvais, L</name>
      </author>
      <author>
        <name>Van Obbergh, L</name>
      </author>
      <author>
        <name>Maucort-Boulch, D</name>
      </author>
      <author>
        <name>Cannesson, M</name>
      </author>
    </item>
    <item>
      <title>The Nutritional Epidemiology Risk–Survival Paradox</title>
      <link>https://escholarship.org/uc/item/5nf2d46g</link>
      <description>A foundational principle of nutritional epidemiology is that certain exposures, such as obesity, alcohol intake, and cholesterol, confer increased risk of chronic diseases. Yet growing evidence indicates that once diseases like cancer or cardiovascular disease are diagnosed, the same exposures may be associated with improved survival outcomes. This phenomenon, which may be considered a risk-survival paradox in nutritional epidemiology, challenges conventional dietary frameworks that assume continuity between disease prevention and disease prognosis. In this perspective article, I examine this paradox through a detailed analysis of 4 key exposures: obesity, alcohol, cholesterol, and antioxidant supplementation, restricted to cancer and cardiovascular disease. These 2 disease areas have the most extensive and methodologically diverse literature documenting risk-survival reversals and are responsible for the highest proportion of global mortality. Key limitations including reverse...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5nf2d46g</guid>
      <pubDate>Thu, 28 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
    </item>
    <item>
      <title>Ultrasound-Guided Percutaneous Cryoneurolysis for Perioperative Analgesia Following Major Lower Extremity Amputation: A Randomized, Participant- and Observer-Masked, Sham-Controlled Pilot Study</title>
      <link>https://escholarship.org/uc/item/7083t9rs</link>
      <description>BACKGROUND: Extremity amputations are associated with pain in both the residual limb and the phantom limb. This pain, which is often debilitating, may be prevented by excellent perioperative pain control. Ultrasound-guided percutaneous cryoneurolysis is an analgesic modality offering pain control for weeks or months following surgery. This treatment has not been compared to the sham procedure for large nerves (e.g., femoral and sciatic) to provide preoperative analgesia. We therefore conducted a randomized, controlled pilot study to evaluate the use of this modality for the treatment of pain following amputation to (1) determine the feasibility of and optimize the study protocol for a subsequent definitive clinical trial; and (2) estimate analgesia and opioid reduction within the first postoperative weeks.
METHODS: A convenience sample of seven patients undergoing lower extremity amputation were randomized to receive either active cryoneurolysis or a sham procedure targeting the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7083t9rs</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Schwartz, Alexandra K</name>
      </author>
      <author>
        <name>Girard, Paul J</name>
      </author>
      <author>
        <name>Kent, William T</name>
      </author>
      <author>
        <name>Al-Nouri, Omar</name>
      </author>
      <author>
        <name>Trescot, Andrea</name>
      </author>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
    </item>
    <item>
      <title>Smallest Clinically Meaningful Improvement in Amputation-Related Pain and Brief Pain Inventory Scores as Defined by Patient Reports of Global Improvement After Cryoneurolysis: a Retrospective Analysis of a Randomized, Controlled Clinical Trial</title>
      <link>https://escholarship.org/uc/item/7071x1j1</link>
      <description>BACKGROUND: The smallest meaningful improvement in pain scores (minimal clinically important difference [MCID]) after an analgesic intervention is essential information when both interpreting published data and designing a clinical trial. However, limited information is available for patients with chronic pain conditions, and what is published is derived from studies involving pharmacologic and psychological interventions. We here calculate these values based on data collected from 144 participants of a previously published multicenter clinical trial investigating the effects of a single treatment with percutaneous cryoneurolysis.
METHODS: In the original trial, we enrolled patients with a lower-limb amputation and established phantom pain. Each received a single-injection femoral and sciatic nerve block with lidocaine and was subsequently randomized to receive either ultrasound-guided percutaneous cryoneurolysis or sham treatment at these same locations. Investigators, participants,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7071x1j1</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Smith, Cameron R</name>
      </author>
      <author>
        <name>Turan, Alparslan</name>
      </author>
      <author>
        <name>Mariano, Edward R</name>
      </author>
      <author>
        <name>Miller, Matthew E</name>
      </author>
      <author>
        <name>Fisher, Rick L</name>
      </author>
      <author>
        <name>Trescot, Andrea M</name>
      </author>
      <author>
        <name>Cohen, Steven P</name>
      </author>
      <author>
        <name>Eisenach, James C</name>
      </author>
      <author>
        <name>Sessler, Daniel I</name>
      </author>
      <author>
        <name>Prologo, J David</name>
      </author>
      <author>
        <name>Mascha, Edward J</name>
      </author>
      <author>
        <name>Liu, Liu</name>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Investigators, the PAINfRE</name>
      </author>
    </item>
    <item>
      <title>Pulsed Shortwave (Radiofrequency) Therapy With a Noninvasive, Wearable, Disposable Device: A Randomized, Participant- and Assessor-Masked, Sham-Controlled Pilot Study</title>
      <link>https://escholarship.org/uc/item/29m6z7gk</link>
      <description>OBJECTIVES: Pulsed shortwave therapy (PSWT) is a nonpharmacologic/noninvasive modality that may offer analgesic benefits without notable side effects or complications. This pilot study aimed to assess the feasibility of a PSWT protocol and provide an estimate of its treatment effects.
MATERIALS AND METHODS: The study included adults who underwent cholecystectomy or unilateral total hip or knee arthroplasty. Participants were randomized to eight days of either PSWT with a single functioning device (SofPulse, Endonovo Therapeutics, Woodland Hills, CA) or a sham device placed over the surgical bandages in a participant- and assessor-masked fashion. The primary end point was the sum of the average and worst (maximum) daily pain intensity as measured with the numeric rating scale collected over the first seven postoperative days.
RESULTS: No systemic side effects or significant complications occurred. During the first seven postoperative days, the sum of the daily pain intensity scores...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/29m6z7gk</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Ball, Scott T</name>
      </author>
      <author>
        <name>Sandler, Bryan J</name>
      </author>
      <author>
        <name>Broderick, Ryan C</name>
      </author>
      <author>
        <name>Gonzales, Francis B</name>
      </author>
      <author>
        <name>Lau, Nathan J</name>
      </author>
      <author>
        <name>Schaar, Adam</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
    </item>
    <item>
      <title>Postoperative and postdischarge nausea and vomiting following ambulatory eye, head, and neck surgeries: a retrospective cohort study comparing incidence and associated factors</title>
      <link>https://escholarship.org/uc/item/1rs1x7db</link>
      <description>BackgroundAmbulatory surgery is often followed by the development of nausea and/or vomiting (N/V). Although risk factors for postoperative nausea and vomiting (PONV) are frequently discussed, the distinction between PONV and postdischarge nausea and vomiting (PDNV) is unclear. This is especially troublesome given the potential consequences of postdischarge nausea and vomiting (PDNV), which include major discomfort and hospital readmission.MethodsIn this retrospective cohort study, data from 10,231 adult patients undergoing ambulatory ophthalmology or otolaryngology procedures with general anesthesia were collected and analyzed. Binary and multinomial logistic regression was used to assess the association between patient and anesthetic characteristics (including age, body mass index (BMI), American Society of Anesthesiologists Physical Status (ASA P/S) classification, current smoker status, and intra- and postoperative opioid usage) and the odds ratios of experiencing only PDNV,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rs1x7db</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Xiao, Mark</name>
      </author>
      <author>
        <name>Yao, Dongdong</name>
      </author>
      <author>
        <name>Fields, Kara G</name>
      </author>
      <author>
        <name>Sarin, Pankaj</name>
      </author>
      <author>
        <name>Macias, Alvaro Andres</name>
        <uri>https://orcid.org/0000-0002-2276-9131</uri>
      </author>
      <author>
        <name>Eappen, Sunil</name>
      </author>
      <author>
        <name>Juang, Jeremy</name>
      </author>
    </item>
    <item>
      <title>Treating intractable postamputation pain with wearable, non-invasive, non-thermal, pulsed shortwave (radiofrequency) therapy: a randomized, double-masked, sham-controlled, crossover pilot study</title>
      <link>https://escholarship.org/uc/item/1jp8567z</link>
      <description>Treating intractable postamputation pain with wearable, non-invasive, non-thermal, pulsed shortwave (radiofrequency) therapy: a randomized, double-masked, sham-controlled, crossover pilot study</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1jp8567z</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>J, Brannon</name>
      </author>
      <author>
        <name>Qian, Andrew S</name>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
    </item>
    <item>
      <title>Paravertebral versus Pectoralis-II (Interpectoral and Pectoserratus) Nerve Blocks for Postoperative Analgesia after Nonmastectomy Breast Surgery: A Randomized, Controlled, Observer-masked Noninferiority Trial</title>
      <link>https://escholarship.org/uc/item/0t34f347</link>
      <description>BACKGROUND: Pectoralis-II and paravertebral nerve blocks are both used to treat pain after breast surgery. Most previous studies involving mastectomy identified little difference of significance between the two approaches. Whether this is also accurate for nonmastectomy procedures remains unknown.
METHODS: Participants undergoing uni- or bilateral nonmastectomy breast surgery anticipated to have at least moderate postoperative pain were randomized to a pectoralis-II or paravertebral block (90 mg ropivacaine per side for both). Surgeons and recovery room staff were masked to treatment group assignment, and participants were not informed of their treatment group. Injectate for pectoralis-II blocks was ropivacaine 0.3% (30 ml) per side. Injectate for paravertebral blocks was ropivacaine 0.5% (9 ml in each of two levels) per side. This study hypothesized that pectoralis-II blocks would have noninferior analgesia (numeric rating scale) and noninferior cumulative opioid consumption...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0t34f347</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Curran, Brian P</name>
      </author>
      <author>
        <name>Swisher, Matthew W</name>
      </author>
      <author>
        <name>Sztain, Jacklynn F</name>
      </author>
      <author>
        <name>Tsuda, Paige S</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Alexander, Brenton</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Abramson, Wendy B</name>
      </author>
      <author>
        <name>Black, Jessica R</name>
      </author>
      <author>
        <name>Wallace, Anne M</name>
      </author>
      <author>
        <name>Blair, Sarah</name>
      </author>
      <author>
        <name>Donohue, Michael C</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>Xu, Nicole Y</name>
      </author>
      <author>
        <name>J., Brannon</name>
      </author>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
    </item>
    <item>
      <title>Percutaneous auricular neuromodulation to treat pain after ambulatory breast surgery: A randomized, double-masked, sham-controlled pilot study</title>
      <link>https://escholarship.org/uc/item/03n9w9hp</link>
      <description>Introduction: Percutaneous auricular neuromodulation involves implanting electrodes around the ear and administering an electric current. A device is currently available that is cleared to treat symptoms from opioid withdrawal, and multiple reports suggest a possible postoperative analgesic effect. This randomized, controlled pilot study aimed to (1) assess the feasibility of a postoperative auricular neuromodulation protocol and (2) provide an estimate of its treatment effects on postoperative pain and opioid consumption.
Methods: Adults undergoing unilateral or bilateral ambulatory breast surgery with anticipated moderate-severe pain and a single-injection paravertebral nerve block(s) received an auricular neuromodulation device (NSS-2 Bridge, Masimo) following surgery. Participants were randomized to 5&amp;nbsp;days of electrical stimulation or sham in a double-masked fashion.
Results: In the first 5 days, the median pain for those receiving active stimulation (&lt;i&gt;n&lt;/i&gt; =&amp;nbsp;15)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/03n9w9hp</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Abramson, Wendy B</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Sztain, Jacklynn F</name>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Griggs, Jonna L</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>Jensen, Evan J</name>
      </author>
      <author>
        <name>Schaar, Adam</name>
      </author>
      <author>
        <name>Wallace, Anne M</name>
      </author>
    </item>
    <item>
      <title>Neuron-targeted caveolin-1 overexpression attenuates cognitive loss and pathological transcriptome changes in symptomatic Alzheimer’s disease models</title>
      <link>https://escholarship.org/uc/item/0h5781xg</link>
      <description>Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive synaptic loss and cognitive decline. Gene therapy that augments intrinsic neuroprotective pathways offers a promising strategy to mitigate neurodegeneration and prevent further cognitive loss. Caveolin-1 (Cav-1), a membrane lipid raft (MLR) scaffolding protein, regulates multiple pro-growth and pro-survival signaling pathways within plasmalemmal microdomains. Previously, we showed that AAV9-Synapsin-promoted Cav-1 (SynCav1) delivered to presymptomatic AD mice preserved cognitive functions and MLR-associated neurotrophic signaling. However, the therapeutic potential of SynCav1 delivered at the symptomatic stage of AD had not been tested. Therefore, the current study investigated the effect of hippocampal SynCav1 delivery at symptomatic age in two distinct preclinical AD models of amyloid pathology: PSAPP and APPKI mice. Our results demonstrated that SynCav1 delivery to PSAPP and APPKI...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0h5781xg</guid>
      <pubDate>Thu, 19 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Dongsheng</name>
      </author>
      <author>
        <name>Chernov, Andrei V</name>
      </author>
      <author>
        <name>Lam, Ryan</name>
      </author>
      <author>
        <name>Wang, Hongxia</name>
      </author>
      <author>
        <name>Li, Wenxi</name>
      </author>
      <author>
        <name>Li, Xiaojing</name>
      </author>
      <author>
        <name>Duong, Tiffany</name>
      </author>
      <author>
        <name>Wang, Shanshan</name>
      </author>
      <author>
        <name>Head, Brian P</name>
      </author>
    </item>
    <item>
      <title>Cryoneurolysis: Major Problems Rarely Discussed (or “Don’t Be Fooled—The Ice Ball Lies!”)</title>
      <link>https://escholarship.org/uc/item/8vn3d9rz</link>
      <description>Cryoneurolysis: Major Problems Rarely Discussed (or “Don’t Be Fooled—The Ice Ball Lies!”)</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8vn3d9rz</guid>
      <pubDate>Thu, 5 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Prologo, J David</name>
      </author>
    </item>
    <item>
      <title>Ultrasound Neuromodulation (Low‐Intensity Focused Ultrasound) to Treat Knee Osteoarthritis Pain</title>
      <link>https://escholarship.org/uc/item/7z71p7b7</link>
      <description>Low-intensity focused ultrasound is a non-invasive neuromodulation technique that delivers mechanical forces to a deep location within the body through acoustic pressure waves without affecting tissue between the transducer and focal target. Preliminary studies involving healthy volunteers suggest focused ultrasound reversibly prevents action potential formation similar to a local anesthetic nerve block, but the modality has not been used in patients with existing pain. The current randomized pilot study was undertaken to 1) determine the feasibility and optimize the protocol for a subsequent definitive clinical trial; and 2) monitor for related complications of focused ultrasound when treating knee osteoarthritis pain.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7z71p7b7</guid>
      <pubDate>Thu, 5 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Cao, Khoa N</name>
      </author>
      <author>
        <name>Branson, Ruben</name>
      </author>
      <author>
        <name>Bloom, Philip</name>
      </author>
    </item>
    <item>
      <title>Multidimensional Analysis of Twin Sets During an Intensive Week-Long Meditation Retreat: A Pilot Study</title>
      <link>https://escholarship.org/uc/item/5h65n04w</link>
      <description>ObjectivesMeditation has long been known to promote health. We utilized a multidisciplinary approach to investigate the impact of mind–body interventions on the body in a twin cohort during a week-long meditation retreat.MethodThis study was designed to address individual changes controlling for intersubject trait variation and explore the role of genetic background on multi-omic factors during meditation. Transcriptomic analysis was carried out from whole blood samples, while metabolomic and biochemical studies were carried out in blood plasma. Quantitative electroencephalography studies, coupled with biometric analysis and molecular studies at multiple time points, were carried out in twins meditating together and in twins separated and simultaneously either meditating or listening to a documentary.ResultsChanges in gene expression, metabolites, and cytokines in blood plasma associated with specific meditative states showed patterns of change relative to the time point being...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5h65n04w</guid>
      <pubDate>Thu, 5 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Zuniga-Hertz, Juan P</name>
      </author>
      <author>
        <name>Simpson, Sierra</name>
      </author>
      <author>
        <name>Chitetti, Ramamurthy</name>
      </author>
      <author>
        <name>Hsu, Chang Francis</name>
      </author>
      <author>
        <name>Huang, Han-Ping</name>
      </author>
      <author>
        <name>Jinich-Diamant, Alex</name>
      </author>
      <author>
        <name>Chernov, Andrei V</name>
      </author>
      <author>
        <name>Onton, Julie A</name>
        <uri>https://orcid.org/0000-0002-5602-3557</uri>
      </author>
      <author>
        <name>Cuomo, Raphael</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
      <author>
        <name>Dispenza, Joe</name>
      </author>
      <author>
        <name>Davis, Dylan</name>
      </author>
      <author>
        <name>Christov-Moore, Leonardo</name>
      </author>
      <author>
        <name>Reggente, Nicco</name>
      </author>
      <author>
        <name>Gu, Wanjun</name>
      </author>
      <author>
        <name>Kong, Mitchell</name>
      </author>
      <author>
        <name>Bonds, Jacqueline A</name>
      </author>
      <author>
        <name>Maree, Jacqueline</name>
      </author>
      <author>
        <name>Simonson, Tatum S</name>
      </author>
      <author>
        <name>Ahn, Andrew C</name>
      </author>
      <author>
        <name>Poirier, Michelle A</name>
      </author>
      <author>
        <name>Moeller-Bertram, Tobias</name>
      </author>
      <author>
        <name>Patel, Hemal H</name>
        <uri>https://orcid.org/0000-0001-6722-9625</uri>
      </author>
    </item>
    <item>
      <title>A Novel Percutaneous Device Enabling both Local Anesthetic Delivery and Electrical Stimulation (Neuromodulation) of Peripheral Nerves for Pain Following Orthopaedic Surgery: An Initial Feasibility Technical Report</title>
      <link>https://escholarship.org/uc/item/0q15g06b</link>
      <description>Introduction: 
 Pain following orthopaedic surgical procedures remains undertreated due to inadequate analgesic options. One possible solution is a novel device currently under investigation. The RELAY system (Gate Science, Moultonborough, NH) is comprised of a basic catheter-over-needle device to allow ultrasound-guided percutaneous insertion, leaving a perineural catheter after simple withdrawal of the internal needle. A single-injection bolus of local anesthetic may be quickly administered. Following surgery, the catheter may be attached to a portable infusion pump to provide an ambulatory continuous peripheral nerve block. Unlike previously described perineural catheters, the RELAY has an embedded wire and integrated pulse generator that permit stimulation of the targeted peripheral nerve(s) for up to 28 days. We here provide the first description of this novel device when used to provide postoperative analgesia. 
   Case Report: 
 A 67-year-old woman undergoing unilateral...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0q15g06b</guid>
      <pubDate>Thu, 5 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Sinha, Sanjay K</name>
      </author>
      <author>
        <name>Leek, Bryan</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
    </item>
    <item>
      <title>Impaired mnemonic pattern separation associated with PTSD symptoms paradoxically improves with regular cannabis use</title>
      <link>https://escholarship.org/uc/item/5f19x38q</link>
      <description>Posttraumatic stress disorder (PTSD) is associated with poor hippocampal function and disrupted pattern recognition. Cannabis use is highly prevalent in individuals with PTSD, yet the impact on these cognitive functions is poorly understood. Participants (n = 111) with a range of PTSD symptoms with and without regular cannabis use completed the mnemonic similarity task. We hypothesized that regular use would be associated with alterations in pattern separation ability in individuals with PTSD symptoms. High PTSD symptoms were associated with reduced pattern separation performance in minimal users. Regular users with high PTSD symptoms showed greater pattern separation, but reduced pattern separation with low PTSD symptoms. These results suggest that regular cannabis use may disrupt pattern separation and similar hippocampal-dependent processes, while it may improve pattern separation in individuals with high PTSD symptoms. These cross-sectional results require longitudinal follow-up...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5f19x38q</guid>
      <pubDate>Thu, 8 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ross, Jacob</name>
      </author>
      <author>
        <name>Cuccurazzu, Bruna</name>
      </author>
      <author>
        <name>Delmar, Dylan</name>
      </author>
      <author>
        <name>Cortez, Christian</name>
      </author>
      <author>
        <name>Castillo, Giovanni</name>
      </author>
      <author>
        <name>Acheson, Dean T</name>
      </author>
      <author>
        <name>Baker, Dewleen G</name>
        <uri>https://orcid.org/0000-0002-1736-9838</uri>
      </author>
      <author>
        <name>Risbrough, Victoria B</name>
      </author>
      <author>
        <name>Stout, Daniel M</name>
      </author>
    </item>
    <item>
      <title>National trends in perioperative epidural analgesia use for surgical patients</title>
      <link>https://escholarship.org/uc/item/6q51z8s6</link>
      <description>STUDY OBJECTIVE: Newer regional anesthesia techniques and minimally invasive surgeries have yielded decreased postoperative pain scores, potentially leading to decreased need for perioperative epidural analgesia. Limited literature is available on trends in usage rates of epidurals. The objective of this study was to identify trends in perioperative epidural analgesia rates among multiple fields of surgery.
METHODS: All patients undergoing general, thoracic, urologic, plastic, vascular, orthopedic, or gynecological surgery in 2014-2020 were included from the National Surgical Quality Improvement Program database of over 700 hospitals in the U.S. and 11 different countries. Annual trends in epidural analgesia for all surgeries and each surgical specialty were assessed by mixed effects multivariable logistic regression. The odds ratios (OR) and 99&amp;nbsp;% confidence intervals (CI) were reported.
RESULTS: There were 3,111,435 patients from 2014 to 2020 that were included in the final...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6q51z8s6</guid>
      <pubDate>Mon, 21 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bongbong, Dale N</name>
      </author>
      <author>
        <name>Abdou, Waseem</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
    </item>
    <item>
      <title>Role of TLR4 activation and signaling in bone remodeling, and afferent sprouting in serum transfer arthritis</title>
      <link>https://escholarship.org/uc/item/5911m9gr</link>
      <description>BackgroundIn the murine K/BxN serum transfer rheumatoid arthritis (RA) model, tactile allodynia persists after resolution of inflammation in male and partially in female wild type (WT) mice, which is absent in Toll-like receptor (TLR)4 deficient animals. We assessed the role of TLR4 on allodynia, bone remodeling and afferent sprouting in this model of arthritis.MethodsK/BxN sera were injected into male and female mice with conditional or stable TLR4 deletion and controls. Paw swelling was scored and allodynia assessed by von Frey filaments. At day 28, synovial neural fibers were visualized with confocal microscopy and bone density assayed with microCT. Microglial activity and TLR4 dimerization in spinal cords were examined by immunofluorescence and flow cytometry.ResultsIn the synovium, K/BxN injected WT male and female mice showed robust increases in calcitonin gene related-peptide (CGRP+), tyrosine hydroxylase (TH)+ and GAP43+ nerve fibers. Trabecular bone density by microCT...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5911m9gr</guid>
      <pubDate>Mon, 21 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>dos Santos, Gilson Goncalves</name>
      </author>
      <author>
        <name>Jiménez-Andrade, Juan Miguel</name>
      </author>
      <author>
        <name>Muñoz-Islas, Enriqueta</name>
      </author>
      <author>
        <name>Candanedo-Quiroz, Mariana E</name>
      </author>
      <author>
        <name>Cardenas, Andrea Gonzalez</name>
      </author>
      <author>
        <name>Drummond, Bronwen</name>
      </author>
      <author>
        <name>Pham, Peter</name>
      </author>
      <author>
        <name>Stilson, Gwendalynn</name>
      </author>
      <author>
        <name>Hsu, Chao-Chin</name>
      </author>
      <author>
        <name>Delay, Lauriane</name>
      </author>
      <author>
        <name>Navia-Pelaez, Juliana M</name>
      </author>
      <author>
        <name>Lemes, Julia Paes</name>
      </author>
      <author>
        <name>Miller, Yury I</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
      <author>
        <name>Corr, Maripat</name>
      </author>
    </item>
    <item>
      <title>A perspective: neuraxial therapeutics in pain management: now and future</title>
      <link>https://escholarship.org/uc/item/25x1876k</link>
      <description>The neuraxial delivery of drugs for the management of pain and other spinal pathologies is widely employed and is the subject of a large volume of ongoing research with several thousand papers appearing in the past 5 years alone on neuraxial delivery. Several learned texts have been recently published. A number of considerations have contributed to this widespread interest in the development of the use of neuraxial therapeutics to manage pain. In the following section, major topics relevant to spinal encoding and in the use of neuraxial therapeutics are considered by the Frontiers in Pain Research editors of the research topic: "&lt;i&gt;Neuraxial Therapeutics in Pain Management: Now and Future"&lt;/i&gt;. This paper seeks to serve as a perspective to encourage the submission of manuscripts reflecting research in this exciting area.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/25x1876k</guid>
      <pubDate>Mon, 21 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>DeAndres, Jose</name>
      </author>
      <author>
        <name>Dickenson, Anthony H</name>
      </author>
      <author>
        <name>Hayek, Salim</name>
      </author>
      <author>
        <name>Linninger, Andreas</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Virally-initiated pain states: phenotypes, mechanisms, and future directions</title>
      <link>https://escholarship.org/uc/item/1tj348fk</link>
      <description>The recent SARS-CoV-2 pandemic has underscored the significance of viral infections, affecting billions of lives and costing trillions of dollars globally. Even beyond SARS-CoV-2, common infections with viruses like influenza, HIV, and herpesviruses have profound impacts beyond their typical manifestations, often triggering acute and chronic pain syndromes that can be life-altering. These virally induced pain states can arise through direct viral replication within neurons, or indirectly, via immune responses to infection in both the contexts of afferent signaling in the dorsal root ganglion (DRG) or subsequent higher order integration in intracranial systems. Varicella-zoster virus (VZV), influenza virus, and SARS-CoV-2 each provide a unique lens through which to examine the interplay between viral activity and pain. This perspective paper is not meant to be an exhaustive review of virally-induced neuropathic pain states. It seeks to explore curated aspects of the complexities...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1tj348fk</guid>
      <pubDate>Mon, 21 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dochnal, Sara A</name>
      </author>
      <author>
        <name>Cohen, Steven P</name>
      </author>
      <author>
        <name>Hutchinson, Mark R</name>
      </author>
      <author>
        <name>Miller, Yury I</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Classifying High-Risk Patients for Persistent Opioid Use After Major Spine Surgery: A Machine-Learning Approach</title>
      <link>https://escholarship.org/uc/item/9gm2r9h9</link>
      <description>BACKGROUND: Persistent opioid use is a common occurrence after surgery and prolonged exposure to opioids may result in escalation and dependence. The objective of this study was to develop machine-learning-based predictive models for persistent opioid use after major spine surgery.
METHODS: Five classification models were evaluated to predict persistent opioid use: logistic regression, random forest, neural network, balanced random forest, and balanced bagging. Synthetic Minority Oversampling Technique was used to improve class balance. The primary outcome was persistent opioid use, defined as patient reporting to use opioids after 3 months postoperatively. The data were split into a training and test set. Performance metrics were evaluated on the test set and included the F1 score and the area under the receiver operating characteristics curve (AUC). Feature importance was ranked based on SHapley Additive exPlanations (SHAP).
RESULTS: After exclusion (patients with missing follow-up...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9gm2r9h9</guid>
      <pubDate>Sat, 19 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Simpson, Sierra</name>
      </author>
      <author>
        <name>Zhong, William</name>
      </author>
      <author>
        <name>Mehdipour, Soraya</name>
      </author>
      <author>
        <name>Armaneous, Michael</name>
      </author>
      <author>
        <name>Sathish, Varshini</name>
      </author>
      <author>
        <name>Walker, Natalie</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
    </item>
    <item>
      <title>Intraarticular monomethyl fumarate as a perspective therapy for osteoarthritis by macrophage polarization</title>
      <link>https://escholarship.org/uc/item/9cf6w8pg</link>
      <description>BackgroundOsteoarthritis (OA) is a chronic disease that may lead to joint structure degeneration, cartilage destruction, osteophyte formation, subchondral bone disruption, and pain. In this scenario, a higher proportion of the proinflammatory macrophage type 1 (M1) than the anti-inflammatory macrophage type 2 (M2) could be highlighted as a hallmark of OA progression. The balance between these two macrophage types emerges as a new therapeutic target in OA. This study aimed to evaluate the analgesia and macrophage profile in the treatment of experimental osteoarthritis (EOA) with systemic dimethyl fumarate (DMF) or local intra-articular monomethyl fumarate (MMF).ResultsDMF via gavage or MMF via intra-articular in the right knee of EOA rats showed improvements in gait parameters and the nociceptive recovery of the mechanical threshold assessment by adapted electronic von Frey treatment on the twenty-first day (long-lasting phase). DMF treatment decreased proinflammatory TNF-α while...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9cf6w8pg</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>de Souza, Douglas Menezes</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>Nishijima, Catarine Massucato</name>
      </author>
      <author>
        <name>de Melo Lima, Bruno Henrique</name>
      </author>
      <author>
        <name>Capetini, Vinicius Cooper</name>
      </author>
      <author>
        <name>de Oliveira, Alexandre LR</name>
      </author>
      <author>
        <name>Anhê, Gabriel Forato</name>
      </author>
      <author>
        <name>Tambeli, Claudia Herrera</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
    </item>
    <item>
      <title>Blocking Pannexin 1 Channels Alleviates Peripheral Inflammatory Pain but not Paclitaxel-Induced Neuropathy</title>
      <link>https://escholarship.org/uc/item/7db5b8rw</link>
      <description>BACKGROUND: Pannexin1 (Panx1) is a membrane channel expressed in different cells of the nervous system and is involved in several pathological conditions, including pain and inflammation. At the central nervous system, the role of Panx1 is already well-established. However, in the periphery, there is a lack of information regarding the participation of Panx1 in neuronal sensitization. The dorsal root ganglion (DRG) is a critical structure for pain processing and modulation. For this reason, understanding the molecular mechanism in the DRG associated with neuronal hypersensitivity has become highly relevant to discovering new possibilities for pain treatment. Here, we aimed to investigate the role of Panx1 in acute nociception and peripheral inflammatory and neuropathic pain by using two different approaches.
METHODS: Rats were treated with a selective Panx1 blocker peptide (10Panx) into L5-DRG, followed by ipsilateral intraplantar injection of carrageenan, formalin, or capsaicin....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7db5b8rw</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Malange, Kaue Franco</name>
      </author>
      <author>
        <name>Carvalho, Nathalia Santos</name>
      </author>
      <author>
        <name>Neves, Amanda Ferreira</name>
      </author>
      <author>
        <name>Urban-Maldonado, Marcia</name>
      </author>
      <author>
        <name>Kempe, Paula Regina Gelinski</name>
      </author>
      <author>
        <name>Nishijima, Catarine Massucato</name>
      </author>
      <author>
        <name>Fagundes, Cecilia Costa</name>
      </author>
      <author>
        <name>Lotufo, Celina Monteiro da Cruz</name>
      </author>
      <author>
        <name>Suadicani, Sylvia Ottile</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
    </item>
    <item>
      <title>Neutrophil-Derived COX-2 has a Key Role during Inflammatory Hyperalgesia</title>
      <link>https://escholarship.org/uc/item/7419f885</link>
      <description>Inflammation
is a vital process for the injured tissue restoration and one of its hallmarks is inflammatory hyperalgesia. The cyclooxygenase (COX) pathway is strongly related to the inflammatory and painful process. Usually, the COX-1 isoform is described as homeostatic, while COX-2 is characterized as inducible in inflammatory conditions. Although it is well known that neutrophil cells are the first to arrive at the inflamed site and the major source of COX-2 is still unknown, the specific role of neutrophil-derived COX-2 in the pain process is. Thus, in the present study, we demonstrate for the first time that neutrophil-derived COX-2 plays a key role in peripheral inflammatory hyperalgesia. Conditional knockout mice for COX-2 in neutrophils (COX-2&amp;nbsp;fl/fl: Mrp8cre±) exhibited higher pain sensitivity after carrageenan (CG) injection and long-lasting IL-1β-induced hyperalgesia compared with the control group (COX-2&amp;nbsp;fl/fl). Also, CG-induced inflammation in COX-2&amp;nbsp;fl/fl:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7419f885</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Carvalho, Nathalia Santos</name>
      </author>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Pagliusi Jr, Marco</name>
      </author>
      <author>
        <name>Machado, Ana Carolina dos Santos</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>Pral, Laís Passariello</name>
      </author>
      <author>
        <name>Fachi, José Luís</name>
      </author>
      <author>
        <name>Nishijima, Catarine Massucato</name>
      </author>
      <author>
        <name>dos Santos, Gilson Gonçalves</name>
      </author>
      <author>
        <name>Tambeli, Claudia Herrera</name>
      </author>
      <author>
        <name>Sartori, Cesar Renato</name>
      </author>
      <author>
        <name>Vinolo, Marco Aurélio Ramirez</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
    </item>
    <item>
      <title>Improved Local Anesthesia at Inflamed Tissue Using the Association of Articaine and Copaiba Oil in Avocado Butter Nanostructured Lipid Carriers</title>
      <link>https://escholarship.org/uc/item/70x9f8jx</link>
      <description>Unsuccessful anesthesia often occurs under an inflammatory tissue environment, making dentistry treatment extremely painful and challenging. Articaine (ATC) is a local anesthetic used at high (4%) concentrations. Since nanopharmaceutical formulations may improve the pharmacokinetics and pharmacodynamics of drugs, we encapsulated ATC in nanostructured lipid carriers (NLCs) aiming to increase the anesthetic effect on the inflamed tissue. Moreover, the lipid nanoparticles were prepared with natural lipids (copaiba (&lt;i&gt;Copaifera langsdorffii&lt;/i&gt;) oil and avocado (&lt;i&gt;Persia gratissima&lt;/i&gt;) butter) that added functional activity to the nanosystem. NLC-CO-A particles (~217 nm) showed an amorphous lipid core structure according to DSC and XDR. In an inflammatory pain model induced by λ-carrageenan in rats, NLC-CO-A improved (30%) the anesthetic efficacy and prolonged anesthesia (3 h) in relation to free ATC. In a PGE2-induced pain model, the natural lipid formulation significantly reduced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/70x9f8jx</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>da Silva, Gustavo Henrique Rodrigues</name>
      </author>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Geronimo, Gabriela</name>
      </author>
      <author>
        <name>de Carvalho, Fabíola Vieira</name>
      </author>
      <author>
        <name>Mendonça, Talita Cesarim</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>de Lima, Fernando Freitas</name>
      </author>
      <author>
        <name>Breitkreitz, Márcia Cristina</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
      <author>
        <name>Costa, Teresa Dalla</name>
      </author>
      <author>
        <name>de Paula, Eneida</name>
      </author>
    </item>
    <item>
      <title>Anti-inflammatory and antinociceptive activities of Croton urucurana Baillon bark</title>
      <link>https://escholarship.org/uc/item/5mg2d1v3</link>
      <description>ETHNOPHARMACOLOGICAL RELEVANCE: Croton urucurana (Euphorbiaceae) is popularly used in Brazil to treat inflammatory processes, pain, and gastric ulcers.
AIM OF STUDY: To evaluate the anti-inflammatory and antinociceptive properties of the methanol extract from the bark of C. urucurana (MECu) in mice and identify its chemical constituents.
MATERIALS AND METHODS: The extract was characterized by UHPLC-DAD-ESI-Q-TOF-MS/MS. Extract doses of 25, 100, and 400mg/kg were employed in the biological assays. Evaluation of anti-inflammatory activity was based on paw edema and leukocyte recruitment into the peritoneal cavity of mice, both induced by carrageenan. Abdominal writhing caused by acetic acid and duration of formalin-induced paw-licking were the models employed to evaluate antinociceptive activity.
RESULTS: Ten compounds were identified in the extract: (+)-gallocatechin (1), procyanidin B3 (2), (+)-catechin (3), (-)-epicatechin (4), tembetarine (5), magnoflorine (6), taspine (7),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5mg2d1v3</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cordeiro, Kátia Wolff</name>
      </author>
      <author>
        <name>Felipe, Josyelen Lousada</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>do Prado, Pâmela Rafaela</name>
      </author>
      <author>
        <name>de Oliveira Figueiredo, Patrícia</name>
      </author>
      <author>
        <name>Garcez, Fernanda Rodrigues</name>
      </author>
      <author>
        <name>de Cássia Freitas, Karine</name>
      </author>
      <author>
        <name>Garcez, Walmir Silva</name>
      </author>
      <author>
        <name>Toffoli-Kadri, Mônica Cristina</name>
      </author>
    </item>
    <item>
      <title>Lipid nanoparticles loaded with butamben and designed to improve anesthesia at inflamed tissues</title>
      <link>https://escholarship.org/uc/item/5hz7x2r3</link>
      <description>The most frequently used local anesthetics (LA) for local infiltration have an ionizable amine in the range of pH 7.6-8.9. Effective anesthesia of inflamed tissues is a great challenge, especially because the induced local acidosis decreases the fraction of the neutral (more potent) LA species in situ. To solve this limitation, the butyl-substituted benzocaine analogue butamben (BTB) - that has no ionizable amine group close to the physiological pH - could be useful if it was not for its low solubility. To overcome the solubility problem, an optimized formulation for BTB using nanostructured lipid carriers (NLC) was developed by a factorial design and characterized using DLS, XRD, DSC and cryo-EM. The release kinetics and cytotoxicity of the new formulation were measured in vitro, while the in vivo tests assessed its effectiveness on healthy and inflamed tissues, in rats. The optimized NLCBTB formulation showed desirable physicochemical properties (size = 235.6 ± 3.9 nm, polydispersity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5hz7x2r3</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Rodrigues da Silva, Gustavo H</name>
      </author>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Geronimo, Gabriela</name>
      </author>
      <author>
        <name>Freitas de Lima, Fernando</name>
      </author>
      <author>
        <name>de Moura, Ludmilla David</name>
      </author>
      <author>
        <name>Carvalho Dos Santos, Ariany</name>
      </author>
      <author>
        <name>Carvalho, Nathalia Santos</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>Breitkreitz, Márcia C</name>
      </author>
      <author>
        <name>Parada, Carlos A</name>
      </author>
      <author>
        <name>de Paula, Eneida</name>
      </author>
    </item>
    <item>
      <title>Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation</title>
      <link>https://escholarship.org/uc/item/4nw879nr</link>
      <description>Several recent studies have established the efficacy of photobiomodulation therapy (PBMT) in painful clinical conditions. Diabetic neuropathy (DN) can be related to activating mitogen-activated protein kinases (MAPK), such as p38, in the peripheral nerve. MAPK pathway is activated in response to extracellular stimuli, including interleukins TNF-α and IL-1β. We verified the pain relief potential of PBMT in streptozotocin (STZ)-induced diabetic neuropathic rats and its influence on the MAPK pathway regulation and calcium (Ca2+) dynamics. We then observed that PBMT applied to the L4-L5 dorsal root ganglion (DRG) region reduced the intensity of hyperalgesia, decreased TNF-α and IL-1β levels, and p38-MAPK mRNA expression in DRG of diabetic neuropathic rats. DN induced the activation of phosphorylated p38 (p-38) MAPK co-localized with TRPV1+ neurons; PBMT partially prevented p-38 activation. DN was related to an increase of p38-MAPK expression due to proinflammatory interleukins, and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4nw879nr</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vieira, Willians Fernando</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>de Magalhães, Silviane Fernandes</name>
      </author>
      <author>
        <name>Lemes, Júlia Borges Paes</name>
      </author>
      <author>
        <name>dos Santos, Gilson Gonçalves</name>
      </author>
      <author>
        <name>Nishijima, Catarine Massucato</name>
      </author>
      <author>
        <name>de Oliveira, Alexandre Leite Rodrigues</name>
      </author>
      <author>
        <name>da Cruz-Höfling, Maria Alice</name>
      </author>
      <author>
        <name>Tambeli, Cláudia Herrera</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
    </item>
    <item>
      <title>Neuraxial drug delivery in pain management: An overview of past, present, and future</title>
      <link>https://escholarship.org/uc/item/4cr9v4vr</link>
      <description>Activation of neuraxial nociceptive linkages leads to a high level of encoding of the message that is transmitted to the brain and that can initiate a pain state with its attendant emotive covariates. As we review here, the encoding of this message is subject to a profound regulation by pharmacological targeting of dorsal root ganglion and dorsal horn systems. Though first shown with the robust and selective modulation by spinal opiates, subsequent work has revealed the pharmacological and biological complexity of these neuraxial systems and points to several regulatory targets. Novel therapeutic delivery platforms, such as viral transfection, antisense and targeted neurotoxins, point to disease-modifying approaches that can selectively address the acute and chronic pain phenotype. Further developments are called for in delivery devices to enhance local distribution and to minimize concentration gradients, as frequently occurs with the poorly mixed intrathecal space. The field...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4cr9v4vr</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
      <author>
        <name>Santos, Gilson Goncalves Dos</name>
      </author>
      <author>
        <name>Borges Paes Lemes, Julia</name>
      </author>
      <author>
        <name>Malange, Kaue</name>
      </author>
    </item>
    <item>
      <title>AGE-RELATED DYSMETABOLISM IS ASSOCIATED WITH CHANGES IN LUMINAL MICROBIOME DYNAMICS</title>
      <link>https://escholarship.org/uc/item/47r0k2cr</link>
      <description>AGE-RELATED DYSMETABOLISM IS ASSOCIATED WITH CHANGES IN LUMINAL MICROBIOME DYNAMICS</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/47r0k2cr</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Russell, Baylee J</name>
      </author>
      <author>
        <name>Maissy, Erica S</name>
      </author>
      <author>
        <name>Allaband, Celeste</name>
      </author>
      <author>
        <name>Patel, Hemal H</name>
        <uri>https://orcid.org/0000-0001-6722-9625</uri>
      </author>
      <author>
        <name>Zarrinpar, Amir</name>
        <uri>https://orcid.org/0000-0001-6423-5982</uri>
      </author>
    </item>
    <item>
      <title>The Implications of Brain-Derived Neurotrophic Factor in the Biological Activities of Platelet-Rich Plasma</title>
      <link>https://escholarship.org/uc/item/3pn1f8kw</link>
      <description>Platelet-rich plasma (PRP) is a biological blood-derived therapeutic obtained from whole blood that contains higher levels of platelets. PRP has been primarily used to mitigate joint degeneration and chronic pain in osteoarthritis (OA). This clinical applicability is based mechanistically on the release of several proteins by platelets that can restore joint homeostasis. Platelets are the primary source of brain-derived neurotrophic factor (BDNF) outside the central nervous system. Interestingly, BDNF and PRP share key biological activities with clinical applicability for OA management, such as anti-inflammatory, anti-apoptotic, and antioxidant. However, the role of BDNF in PRP therapeutic activities is still unknown. Thus, this work aimed to investigate the implications of BDNF in therapeutic outcomes provided by PRP therapy in vitro and in-vivo, using the MIA-OA animal model in male Wistar rats. Initially, the PRP was characterized, obtaining a leukocyte-poor-platelet-rich plasma...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3pn1f8kw</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Malange, Kaue Franco</name>
      </author>
      <author>
        <name>de Souza, Douglas Menezes</name>
      </author>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Fagundes, Cecilia Costa</name>
      </author>
      <author>
        <name>Oliveira, Anna Lethicia Lima</name>
      </author>
      <author>
        <name>Pagliusi, Marco Oreste</name>
      </author>
      <author>
        <name>Carvalho, Nathalia Santos</name>
      </author>
      <author>
        <name>Nishijima, Catarine Massucato</name>
      </author>
      <author>
        <name>da Silva, Cintia Rizoli Ruiz</name>
      </author>
      <author>
        <name>Consonni, Silvio Roberto</name>
      </author>
      <author>
        <name>Sartori, Cesar Renato</name>
      </author>
      <author>
        <name>Tambeli, Claudia Herrera</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
    </item>
    <item>
      <title>Tabebuia aurea decreases hyperalgesia and neuronal injury induced by snake venom</title>
      <link>https://escholarship.org/uc/item/3mj638rj</link>
      <description>ETHNOPHARMACOLOGICAL RELEVANCE: Tabebuia aurea (Silva Manso) Benth. &amp;amp; Hook. f. ex S. Moore is used as anti-inflammatory, analgesic and antiophidic in traditional medicine, though its pharmacological proprieties are still underexplored. In the bothropic envenoming, pain is a key symptom drove by an intense local inflammatory and neurotoxic event. The antivenom serum therapy is still the main treatment despite its poor local effects against pain and tissue injury. Furthermore, it is limited to ambulatorial niches, giving space for the search of new and more inclusive pharmacological approaches.
AIM OF THE STUDY: evaluation of Tabebuia aurea hydroethanolic extract (HEETa) in hyperalgesia and neuronal injury induced by Bothrops mattogrossensis venom (VBm).
MATERIALS AND METHODS: Stem barks from Tabebuia aurea were extracted with ethanol and water (7:3, v/v) to yield the extract HEETa. Then, HEETa was analyzed by LC-DAD-MS and its constituents were identified. Snake venoms were...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3mj638rj</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>Dos Santos, Gilson Gonçalves</name>
      </author>
      <author>
        <name>Kato, Natália Naomi</name>
      </author>
      <author>
        <name>Toffoli-Kadri, Mônica Cristina</name>
      </author>
      <author>
        <name>Carollo, Carlos Alexandre</name>
      </author>
      <author>
        <name>Silva, Denise Brentan</name>
      </author>
      <author>
        <name>Portugal, Luciane Candeloro</name>
      </author>
      <author>
        <name>Alves, Flávio Macedo</name>
      </author>
      <author>
        <name>Rita, Paula Helena Santa</name>
      </author>
      <author>
        <name>Parada, Carlos Amílcar</name>
      </author>
      <author>
        <name>Rondon, Eric Schmidt</name>
      </author>
    </item>
    <item>
      <title>Photobiomodulation therapy for osteoarthritis: Mechanisms of action</title>
      <link>https://escholarship.org/uc/item/2m37s5x2</link>
      <description>Photobiomodulation therapy for osteoarthritis: Mechanisms of action</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2m37s5x2</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Giolo, Fábio Pericinoto</name>
      </author>
      <author>
        <name>Santos, Gabriel Silva</name>
      </author>
      <author>
        <name>Pacheco, Victor Fontes</name>
      </author>
      <author>
        <name>Huber, Stephany Cares</name>
      </author>
      <author>
        <name>Malange, Kaue Franco</name>
      </author>
      <author>
        <name>Rodrigues, Bruno Lima</name>
      </author>
      <author>
        <name>Bassora, Fernanda</name>
      </author>
      <author>
        <name>Mosaner, Tomas</name>
      </author>
      <author>
        <name>Azzini, Gabriel</name>
      </author>
      <author>
        <name>Ribeiro, Lucas Leite</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
      <author>
        <name>Lana, José Fábio Santos Duarte</name>
      </author>
    </item>
    <item>
      <title>Gait analysis correlates mechanical hyperalgesia in a model of streptozotocin-induced diabetic neuropathy: A CatWalk dynamic motor function study</title>
      <link>https://escholarship.org/uc/item/09m592z2</link>
      <description>Peripheral neuropathy is a complication of diabetes commonly associated with pain and decline in motor compound action potential, leading to alterations in plantar pressure during gait. We identified motor impairments in streptozotocin (STZ)-induced diabetic neuropathic rats and correlated with mechanical withdrawal thresholds, establishing this correlation as a complementary method to investigate the development of chronic hyperalgesia in diabetic neuropathy.
METHODS: UNICAMP's Ethics Committee (protocol number 3902-1) approved all experiments. Male Lewis rats (200-250 g) received a STZ-low-dose (25 mg/kg/day) (STZ group) or 0.1 M sodium citrate buffer (SCB, control group) once a day, during five consecutive days. Diabetic rats (250 mg/dL blood glucose) were submitted to electronic von Frey and CatWalk tests at 0, 7, 14, 21, and 28 days after treatment.
RESULTS: STZ, but not SCB, induced diabetes. After the 14&lt;sup&gt;th&lt;/sup&gt; day (STZ)-induced diabetic rats showed mechanical hyperalgesia...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/09m592z2</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vieira, Willians Fernando</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>de Magalhães, Silviane Fernandes</name>
      </author>
      <author>
        <name>Dos Santos, Gilson Gonçalves</name>
      </author>
      <author>
        <name>de Oliveira, Alexandre Leite Rodrigues</name>
      </author>
      <author>
        <name>da Cruz-Höfling, Maria Alice</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
    </item>
    <item>
      <title>Improved Local Anesthesia at Inflamed Tissue Using the Association of Articaine and Copaiba Oil in Avocado Butter Nanostructured Lipid Carriers</title>
      <link>https://escholarship.org/uc/item/41d4n076</link>
      <description>Unsuccessful anesthesia often occurs under an inflammatory tissue environment, making dentistry treatment extremely painful and challenging. Articaine (ATC) is a local anesthetic used at high (4%) concentrations. Since nanopharmaceutical formulations may improve the pharmacokinetics and pharmacodynamics of drugs, we encapsulated ATC in nanostructured lipid carriers (NLCs) aiming to increase the anesthetic effect on the inflamed tissue. Moreover, the lipid nanoparticles were prepared with natural lipids (copaiba (&lt;i&gt;Copaifera langsdorffii&lt;/i&gt;) oil and avocado (&lt;i&gt;Persia gratissima&lt;/i&gt;) butter) that added functional activity to the nanosystem. NLC-CO-A particles (~217 nm) showed an amorphous lipid core structure according to DSC and XDR. In an inflammatory pain model induced by λ-carrageenan in rats, NLC-CO-A improved (30%) the anesthetic efficacy and prolonged anesthesia (3 h) in relation to free ATC. In a PGE2-induced pain model, the natural lipid formulation significantly reduced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/41d4n076</guid>
      <pubDate>Fri, 4 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>da Silva, Gustavo Henrique Rodrigues</name>
      </author>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Geronimo, Gabriela</name>
      </author>
      <author>
        <name>de Carvalho, Fabíola Vieira</name>
      </author>
      <author>
        <name>Mendonça, Talita Cesarim</name>
      </author>
      <author>
        <name>Malange, Kauê Franco</name>
      </author>
      <author>
        <name>de Lima, Fernando Freitas</name>
      </author>
      <author>
        <name>Breitkreitz, Márcia Cristina</name>
      </author>
      <author>
        <name>Parada, Carlos Amilcar</name>
      </author>
      <author>
        <name>Costa, Teresa Dalla</name>
      </author>
      <author>
        <name>de Paula, Eneida</name>
      </author>
    </item>
    <item>
      <title>Pain Management Following Total Hip Arthroplasty With Percutaneous Auricular Stimulation (Neuromodulation): A Randomized, Double-Masked, Sham-Controlled Pilot Study</title>
      <link>https://escholarship.org/uc/item/3690591v</link>
      <description>Objectives Percutaneous auricular neuromodulation involves implanting electrodes around the ear and administering an electric current. A device is currently available in the United States, cleared to treat symptoms from opioid withdrawal, with multiple reports suggesting a possible postoperative analgesic effect. This randomized, controlled pilot study aimed to (1) assess the feasibility of a postoperative auricular neuromodulation protocol&amp;nbsp;and (2) provide an estimate of its treatment effects on postoperative pain and opioid consumption following total hip arthroplasty. Methods Adults undergoing unilateral, primary, total hip arthroplasty received an auricular neuromodulation device (NSS-2 Bridge&lt;sup&gt;TM&lt;/sup&gt;, Masimo, Irvine, California) applied following surgery. Participants were randomized to five days of either electrical stimulation or sham in a double-masked fashion and discharged home with their devices &lt;i&gt;in situ&lt;/i&gt;. Participants or their caretakers removed the devices...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3690591v</guid>
      <pubDate>Fri, 4 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Alexander, Brenton S</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>Ball, Scott T</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>Jensen, Evan J</name>
      </author>
      <author>
        <name>Schaar, Adam</name>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
    </item>
    <item>
      <title>A Review of Leveraging Artificial Intelligence to Predict Persistent Postoperative Opioid Use and Opioid Use Disorder and its Ethical Considerations</title>
      <link>https://escholarship.org/uc/item/3n92w9wx</link>
      <description>Purpose of ReviewArtificial intelligence (AI) offers a new frontier for aiding in the management of both acute and chronic pain, which may potentially transform opioid prescribing practices and addiction prevention strategies. In this review paper, not only do we discuss some of the current literature around predicting various opioid-related outcomes, but we also briefly point out the next steps to improve trustworthiness of these AI models prior to real-time use in clinical workflow.Recent FindingsMachine learning-based predictive models for identifying risk for persistent postoperative opioid use have been reported for spine surgery, knee arthroplasty, hip arthroplasty, arthroscopic joint surgery, outpatient surgery, and mixed surgical populations. Several machine learning-based models have been described to predict an individual’s propensity for opioid use disorder and opioid overdose. Natural language processing and large language model approaches have been described to detect...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3n92w9wx</guid>
      <pubDate>Tue, 1 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Park, Brian H</name>
        <uri>https://orcid.org/0000-0003-2916-5696</uri>
      </author>
      <author>
        <name>Hsu, Chun-Nan</name>
      </author>
      <author>
        <name>Macias, Alvaro A</name>
        <uri>https://orcid.org/0000-0002-2276-9131</uri>
      </author>
    </item>
    <item>
      <title>Representation of commercial and traditional tobacco on social media: deconstructing historical narratives to address the Indigenous youth tobacco epidemic</title>
      <link>https://escholarship.org/uc/item/82d9c3r7</link>
      <description>BACKGROUND: Tobacco has significant cultural and spiritual uses in many Indigenous communities. The tobacco industry has long appropriated American Indian or Alaska Native (AI/AN or Indigenous) cultural imagery in print media and signage to advertise commercial tobacco products. In the internet era, little is known about the representation of commercial tobacco product advertising using AI/AN terms and images on social media.
METHODS: With structured platform searches, custom data collection approaches and a combination of manual content analysis and natural language processing approaches (NLP), we identified and characterised content using the hashtag #TraditionalTobacco (specific to Indigenous contexts) on Instagram and Twitter.
RESULTS: Using a combination of manual annotation and NLP, we identified prevalent themes and discussion topics, such as misrepresentation of traditional AI/AN uses of tobacco, appropriation of AI/AN imagery in retail advertising of tobacco and different...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/82d9c3r7</guid>
      <pubDate>Fri, 28 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Calac, Alec J</name>
      </author>
      <author>
        <name>McMann, Tiana</name>
      </author>
      <author>
        <name>Li, Zhuoran</name>
      </author>
      <author>
        <name>Cuomo, Raphael</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
      <author>
        <name>Mackey, Timothy K</name>
      </author>
    </item>
    <item>
      <title>Chronic Pain Induced by Social Defeat Stress in Juvenile Mice Depends on TLR4</title>
      <link>https://escholarship.org/uc/item/3jj771b8</link>
      <description>A significant portion of adolescents suffer from mental illnesses and persistent pain due to repeated stress. The components of the nervous system that link stress and pain in early life remain unclear. Prior studies in adult mice implicated the innate immune system, specifically Toll-like receptors (TLRs), as critical for inducing long-term anxiety and pain-like behaviors in social defeat stress (SDS) models. In this work, we investigated the pain and anxiety behavioral phenotypes of wild-type and TLR4-deficient juvenile mice subjected to repeated SDS and evaluated the engagement of TLR4 by measuring dimerization in the spinal cord, dorsal root ganglia, and prefrontal cortex. Male juvenile (4-week-old) mice (C57BL/6J or &lt;i&gt;Tlr4&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt;) underwent six social defeat sessions with adult aggressor (CD1) mice. In WT mice, SDS promotes chronic mechanical allodynia and thermal hyperalgesia assessed via von Frey testing and the Hargreaves test, respectively. In parallel, the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3jj771b8</guid>
      <pubDate>Thu, 27 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lemes, Julia Borges Paes</name>
      </author>
      <author>
        <name>Panichkina, Alisa</name>
      </author>
      <author>
        <name>Malange, Kaue Franco</name>
      </author>
      <author>
        <name>Morado-Urbina, Carlos E</name>
      </author>
      <author>
        <name>Dochnal, Sara Anna</name>
      </author>
      <author>
        <name>Jadhav, Saee</name>
      </author>
      <author>
        <name>Dolmat, Maksim</name>
      </author>
      <author>
        <name>Pagliusi, Marco</name>
      </author>
      <author>
        <name>Navia-Pealez, Juliana M</name>
      </author>
      <author>
        <name>Corr, Maripat</name>
      </author>
      <author>
        <name>Miller, Yury I</name>
        <uri>https://orcid.org/0000-0003-0521-7690</uri>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Acetaminophen effects upon formalin-evoked flinching, postformalin, and postincisional allodynia and conditioned place preference</title>
      <link>https://escholarship.org/uc/item/2025d9g8</link>
      <description>Introduction: We explored in mice, the analgesic, tolerance, dependency, and rewarding effects of systemic acetaminophen (APAP).
Methods: Studies employed adult mice (C57Bl6). (1) &lt;i&gt;Intraplantar formalin flinching + post formalin allodynia&lt;/i&gt;. Mice were given intraperitoneal APAP in a DMSO (5%)/Tween 80 (5%) or a water-based formulation before formalin flinching on day 1 and tactile thresholds assessed before and after APAP at day 12. (2) &lt;i&gt;Paw incision.&lt;/i&gt; At 24 hours and 8 days after hind paw incision in male mice, effects of intraperitoneal APAP on tactile allodynia were assessed. (3) &lt;i&gt;Repeated delivery&lt;/i&gt;. Mice received daily (4 days) analgesic doses of APAP or vehicle and tested upon formalin flinching on day 5. (4) &lt;i&gt;Conditioned place preference&lt;/i&gt;. For 3 consecutive days, vehicle was given in the morning in either of 2 chambers and in each afternoon, an analgesic dose of morphine or APAP in the other chamber. On days 5 and 10, animals were allowed to select a "preferred"...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2025d9g8</guid>
      <pubDate>Mon, 24 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Yun, Mijung</name>
      </author>
      <author>
        <name>Regen, Naemi Ditlevsen</name>
      </author>
      <author>
        <name>Anchondo, Yuvicza</name>
      </author>
      <author>
        <name>Eddinger, Kelly</name>
      </author>
      <author>
        <name>Malkmus, Shelle</name>
      </author>
      <author>
        <name>Roberts, Steven W</name>
      </author>
      <author>
        <name>Donati, Elisabetta</name>
      </author>
      <author>
        <name>Leonardi, Antonio</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Transcranial volumetric imaging using a conformal ultrasound patch</title>
      <link>https://escholarship.org/uc/item/60b4r3zz</link>
      <description>Accurate and continuous monitoring of cerebral blood flow is valuable for clinical neurocritical care and fundamental neurovascular research. Transcranial Doppler (TCD) ultrasonography is a widely used non-invasive method for evaluating cerebral blood flow1, but the conventional rigid design severely limits the measurement accuracy of the complex three-dimensional (3D) vascular networks and the practicality for prolonged recording2. Here we report a conformal ultrasound patch for hands-free volumetric imaging and continuous monitoring of cerebral blood flow. The 2 MHz ultrasound waves reduce the attenuation and phase aberration caused by the skull, and the copper mesh shielding layer provides conformal contact to the skin while improving the signal-to-noise ratio by 5 dB. Ultrafast ultrasound imaging based on diverging waves can accurately render the circle of Willis in 3D and minimize human errors during examinations. Focused ultrasound waves allow the recording of blood flow...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/60b4r3zz</guid>
      <pubDate>Fri, 21 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Zhou, Sai</name>
      </author>
      <author>
        <name>Gao, Xiaoxiang</name>
      </author>
      <author>
        <name>Park, Geonho</name>
        <uri>https://orcid.org/0000-0002-1976-4460</uri>
      </author>
      <author>
        <name>Yang, Xinyi</name>
      </author>
      <author>
        <name>Qi, Baiyan</name>
      </author>
      <author>
        <name>Lin, Muyang</name>
      </author>
      <author>
        <name>Huang, Hao</name>
      </author>
      <author>
        <name>Bian, Yizhou</name>
      </author>
      <author>
        <name>Hu, Hongjie</name>
      </author>
      <author>
        <name>Chen, Xiangjun</name>
      </author>
      <author>
        <name>Wu, Ray S</name>
      </author>
      <author>
        <name>Liu, Boyu</name>
      </author>
      <author>
        <name>Yue, Wentong</name>
      </author>
      <author>
        <name>Lu, Chengchangfeng</name>
        <uri>https://orcid.org/0000-0003-3807-9917</uri>
      </author>
      <author>
        <name>Wang, Ruotao</name>
      </author>
      <author>
        <name>Bheemreddy, Pranavi</name>
      </author>
      <author>
        <name>Qin, Siyu</name>
      </author>
      <author>
        <name>Lam, Arthur</name>
      </author>
      <author>
        <name>Wear, Keith A</name>
      </author>
      <author>
        <name>Andre, Michael</name>
        <uri>https://orcid.org/0000-0001-8744-4808</uri>
      </author>
      <author>
        <name>Kistler, Erik B</name>
        <uri>https://orcid.org/0000-0002-6512-4798</uri>
      </author>
      <author>
        <name>Newell, David W</name>
      </author>
      <author>
        <name>Xu, Sheng</name>
        <uri>https://orcid.org/0000-0002-3120-4992</uri>
      </author>
    </item>
    <item>
      <title>Assessing tobacco retailer compliance with flavoured tobacco product sales restrictions: a cross-sectional study of four California cities</title>
      <link>https://escholarship.org/uc/item/7c66p129</link>
      <description>Background: Governments are passing laws to restrict the sale of flavoured tobacco products (FTPs), but retailer compliance with such policies may vary. This study compared tobacco retailer compliance with local ordinances restricting the sale of FTPs across various localities in Southern California.
Methods: Attempts to purchase FTPs from a random sample of tobacco retailers in a convenience sample of four cities in Southern California with FTP sales restrictions were made from June to August 2022. Trained shoppers of legal tobacco purchasing age entered tobacco retailers and purchased prohibited FTPs if they were on display or asked salespersons for menthol cigarettes or a flavoured e-cigarette, completing purchases if they were made available.
Results: Among 141 stores, 39.9% of stores were non-compliant with local ordinances. Non-compliance varied by city, occurring in 49.3%, 43.8%, 15.4% and 0% of stores across four cities. The highest proportion of non-compliance was among...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7c66p129</guid>
      <pubDate>Wed, 19 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Yang, Joshua S</name>
      </author>
      <author>
        <name>Cuomo, Raphael</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
      <author>
        <name>Nguyen, Quincy</name>
      </author>
      <author>
        <name>Merrill, Regina</name>
      </author>
      <author>
        <name>McMann, Tiana</name>
      </author>
      <author>
        <name>Nali, Matthew</name>
        <uri>https://orcid.org/0000-0002-0565-8202</uri>
      </author>
      <author>
        <name>Gooneratne, Chrismarie</name>
      </author>
      <author>
        <name>Le, Nicolette</name>
      </author>
      <author>
        <name>Cui, Mandy</name>
      </author>
      <author>
        <name>Mackey, Tim K</name>
      </author>
    </item>
    <item>
      <title>Rare presentation of Pseudomonas aeruginosa meningitis following intrathecal pump replacement</title>
      <link>https://escholarship.org/uc/item/6nh5r445</link>
      <description>Rare presentation of Pseudomonas aeruginosa meningitis following intrathecal pump replacement</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6nh5r445</guid>
      <pubDate>Tue, 18 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ghaffari, Cyrus</name>
      </author>
      <author>
        <name>Reddy, Rajiv</name>
      </author>
      <author>
        <name>Furnish, Tim</name>
      </author>
    </item>
    <item>
      <title>Percutaneous auricular neuromodulation (nerve stimulation) for the treatment of pain following total knee arthroplasty: a randomized, double-masked, sham-controlled pilot study</title>
      <link>https://escholarship.org/uc/item/1v02q7nh</link>
      <description>BACKGROUND: Percutaneous auricular nerve stimulation (neuromodulation) is an analgesic technique involving the percutaneous implantation of multiple leads at various points on/around the ear followed by the delivery of electric current using an external pulse generator. A device is currently available within the USA cleared to treat symptoms from opioid withdrawal, and multiple reports suggest a possible postoperative analgesic effect. The current randomized, controlled pilot study was undertaken to (1) determine the feasibility and optimize the protocol for a subsequent definitive clinical trial and (2) estimate the treatment effect of auricular neuromodulation on postoperative pain and opioid consumption following total knee arthroplasty.
METHODS: Within the recovery room following primary, unilateral, total knee arthroplasty, an auricular neuromodulation device (NSS-2 Bridge, Masimo, Irvine, California, USA) was applied using three percutaneous leads and one ground electrode....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1v02q7nh</guid>
      <pubDate>Tue, 18 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Alexander, Brenton</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>Abramson, Wendy B</name>
      </author>
      <author>
        <name>Sztain, Jacklynn F</name>
      </author>
      <author>
        <name>Ball, Scott T</name>
      </author>
      <author>
        <name>Gonzales, Francis B</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>J, Brannon</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
    </item>
    <item>
      <title>Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics</title>
      <link>https://escholarship.org/uc/item/8bc6x1r2</link>
      <description>Traumatic brain injury (TBI) is one of the leading causes of death of young people in the developed world. In the United States alone, 1.7 million traumatic events occur annually accounting for 50,000 deaths. The etiology of TBI includes traffic accidents, falls, gunshot wounds, sports, and combat-related events. TBI severity ranges from mild to severe. TBI can induce subtle changes in molecular signaling, alterations in cellular structure and function, and/or primary tissue injury, such as contusion, hemorrhage, and diffuse axonal injury. TBI results in blood–brain barrier (BBB) damage and leakage, which allows for increased extravasation of immune cells (i.e., increased neuroinflammation). BBB dysfunction and impaired homeostasis contribute to secondary injury that occurs from hours to days to months after the initial trauma. This delayed nature of the secondary injury suggests a potential therapeutic window. The focus of this article is on the (1) pathophysiology of TBI and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8bc6x1r2</guid>
      <pubDate>Mon, 17 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Pearn, Matthew L</name>
      </author>
      <author>
        <name>Niesman, Ingrid R</name>
      </author>
      <author>
        <name>Egawa, Junji</name>
      </author>
      <author>
        <name>Sawada, Atsushi</name>
      </author>
      <author>
        <name>Almenar-Queralt, Angels</name>
      </author>
      <author>
        <name>Shah, Sameer B</name>
      </author>
      <author>
        <name>Duckworth, Josh L</name>
      </author>
      <author>
        <name>Head, Brian P</name>
      </author>
    </item>
    <item>
      <title>On the development and validation of large language model-based classifiers for identifying social determinants of health</title>
      <link>https://escholarship.org/uc/item/9rv4119p</link>
      <description>The assessment of social determinants of health (SDoH) within healthcare systems is crucial for comprehensive patient care and addressing health disparities. Current challenges arise from the limited inclusion of structured SDoH information within electronic health record (EHR) systems, often due to the lack of standardized diagnosis codes. This study delves into the transformative potential of large language models (LLM) to overcome these challenges. LLM-based classifiers-using Bidirectional Encoder Representations from Transformers (BERT) and A Robustly Optimized BERT Pretraining Approach (RoBERTa)-were developed for SDoH concepts, including homelessness, food insecurity, and domestic violence, using synthetic training datasets generated by generative pre-trained transformers combined with authentic clinical notes. Models were then validated on separate datasets: Medical Information Mart for Intensive Care-III and our institutional EHR data. When training the model with a combination...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9rv4119p</guid>
      <pubDate>Mon, 24 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Litake, Onkar</name>
      </author>
      <author>
        <name>Simpson, Sierra</name>
      </author>
      <author>
        <name>Burton, Brittany N</name>
        <uri>https://orcid.org/0000-0001-7078-2480</uri>
      </author>
      <author>
        <name>Waterman, Ruth S</name>
      </author>
      <author>
        <name>Macias, Alvaro A</name>
        <uri>https://orcid.org/0000-0002-2276-9131</uri>
      </author>
    </item>
    <item>
      <title>Ultrasound-guided Percutaneous Cryoneurolysis for the Treatment of Pain after Traumatic Rib Fracture: A Randomized, Active-controlled, Participant- and Observer-masked Study</title>
      <link>https://escholarship.org/uc/item/43b1q2t1</link>
      <description>BACKGROUND: Traumatic rib fractures are associated with pain lasting weeks to months and a decreased ability to inspire deeply or cough to clear secretions. Ultrasound-guided percutaneous cryoneurolysis involves reversibly ablating peripheral nerve(s) using exceptionally low temperature with a transdermal probe, resulting in a prolonged nerve block with a duration measured in months. The authors hypothesized that cryoneurolysis would improve analgesia and inspired volume after rib fracture.
METHODS: Adults with one to six traumatic rib fractures were randomized to either active cryoneurolysis and sham peripheral nerve block or sham cryoneurolysis and active peripheral nerve block in a participant/observer-masked fashion. The primary endpoint was the maximum inspired volume the day after the procedure as measured with an incentive spirometer.
RESULTS: The day after the procedure, the unadjusted median [interquartile range] maximum inspired volume for participants who received cryoneurolysis...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/43b1q2t1</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Kobayashi, Leslie</name>
      </author>
      <author>
        <name>Costantini, Todd W</name>
      </author>
      <author>
        <name>Weaver, Jessica L</name>
      </author>
      <author>
        <name>Berndtson, Allison E</name>
      </author>
      <author>
        <name>Haines, Laura</name>
      </author>
      <author>
        <name>Doucet, Jay J</name>
      </author>
      <author>
        <name>Adams, Laura</name>
      </author>
      <author>
        <name>Santorelli, Jarrett E</name>
      </author>
      <author>
        <name>Lee, Jeanne</name>
      </author>
      <author>
        <name>Trescot, Andrea M</name>
      </author>
      <author>
        <name>Donohue, Michael C</name>
      </author>
      <author>
        <name>Schaar, Adam</name>
      </author>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
    </item>
    <item>
      <title>Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation</title>
      <link>https://escholarship.org/uc/item/9w06b1h0</link>
      <description>The field of bioelectronic medicine has advanced rapidly from rudimentary electrical therapies to cutting-edge closed-loop systems that integrate real-time physiological monitoring with adaptive neuromodulation. Early innovations, such as cardiac pacemakers and deep brain stimulation, paved the way for these sophisticated technologies. This review traces the historical and technological progression of bioelectronic medicine, culminating in the emerging potential of closed-loop devices for multiple disorders of the brain and body. We emphasize both invasive techniques, such as implantable devices for brain, spinal cord and autonomic regulation, while we introduce new prospects for non-invasive neuromodulation, including focused ultrasound and newly developed autonomic neurography enabling precise detection and titration of inflammatory immune responses. The case for closed-loop non-invasive autonomic neuromodulation (incorporating autonomic neurography and splenic focused ultrasound...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9w06b1h0</guid>
      <pubDate>Fri, 31 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lerman, Imanuel</name>
        <uri>https://orcid.org/0000-0002-6564-7222</uri>
      </author>
      <author>
        <name>Bu, Yifeng</name>
      </author>
      <author>
        <name>Singh, Rahul</name>
      </author>
      <author>
        <name>Silverman, Harold A</name>
      </author>
      <author>
        <name>Bhardwaj, Anuj</name>
      </author>
      <author>
        <name>Mann, Alex J</name>
      </author>
      <author>
        <name>Widge, Alik</name>
      </author>
      <author>
        <name>Palin, Joseph</name>
      </author>
      <author>
        <name>Puleo, Christopher</name>
      </author>
      <author>
        <name>Lim, Hubert</name>
      </author>
    </item>
    <item>
      <title>Demographic disparities in access to COVID-19 clinical trial sites across the United States: a geospatial analysis</title>
      <link>https://escholarship.org/uc/item/6f89v97p</link>
      <description>Throughout the COVID-19 pandemic, underserved populations, such as racial and ethnic minority communities, were disproportionately impacted by illness and death. Ensuring people from diverse backgrounds have the ability to participate in clinical trials is key to advancing health equity. We sought to analyze the spatial variability in locations of COVID-19 trials sites and to test associations with demographic correlates. All available and searchable COVID-19 studies listed on ClinicalTrials.gov until 04/04/2022 and conducted in the United States were extracted at the trial-level, and locations were geocoded using the Microsoft Bing API. Publicly available demographic data were available at the county level for national analysis and the census tract level for local analysis. Independent variables included eight racial and ethnic covariates, both sexes, and twelve age categories, all of which were population-normalized. The county-level, population-normalized count of study site...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6f89v97p</guid>
      <pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cuomo, Raphael</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
      <author>
        <name>McMann, Tiana</name>
      </author>
      <author>
        <name>Xu, Qing</name>
      </author>
      <author>
        <name>Li, Zhuoran</name>
      </author>
      <author>
        <name>Yang, Joshua</name>
      </author>
      <author>
        <name>Hsieh, Julie</name>
      </author>
      <author>
        <name>Lee, Christine</name>
      </author>
      <author>
        <name>Lolic, Milena</name>
      </author>
      <author>
        <name>Araojo, Richardae</name>
      </author>
      <author>
        <name>Mackey, Tim</name>
      </author>
    </item>
    <item>
      <title>Expedited Awakening at Foundation for African Medicine and Education [FAME], Tanzania by the Adsorption of Anesthetic Gas to Activated Charcoal in a Reusable Container</title>
      <link>https://escholarship.org/uc/item/4pr2r6q3</link>
      <description>Expedited Awakening at Foundation for African Medicine and Education [FAME], Tanzania by the Adsorption of Anesthetic Gas to Activated Charcoal in a Reusable Container</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4pr2r6q3</guid>
      <pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Schneider, Edward A</name>
      </author>
      <author>
        <name>Mganga, Sehewa</name>
      </author>
      <author>
        <name>Hayek, Daniel A</name>
      </author>
      <author>
        <name>Sanghvi, Reema I</name>
        <uri>https://orcid.org/0000-0003-0796-6919</uri>
      </author>
    </item>
    <item>
      <title>Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for postoperative analgesia: A randomized, double‐masked, sham‐controlled pilot study</title>
      <link>https://escholarship.org/uc/item/2c73v2p8</link>
      <description>BACKGROUND: Nonthermal, pulsed shortwave (radiofrequency) therapy (PSWT) is a nonpharmacologic, noninvasive modality that limited evidence suggests provides analgesia. Its potential favorable risk-benefit ratio stems from its lack of side effects and significant medical risks, applicability to any anatomic location, long treatment duration, and ease of application by simply affixing it with tape. Even with a relatively small treatment effect, PSWT might contribute to a multimodal analgesic regimen, similar to acetaminophen. However, widespread clinical use is hindered by a lack of systematic evidence. The current randomized, controlled pilot study was undertaken to determine the feasibility and optimize the protocol for a subsequent definitive investigation and estimate the treatment effect of PSWT on postoperative pain and opioid consumption.
METHODS: Within the recovery room following primary knee and hip arthroplasty, cholecystectomy, hernia repair, and non-mastectomy breast...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2c73v2p8</guid>
      <pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Ball, Scott T</name>
      </author>
      <author>
        <name>Wallace, Anne M</name>
      </author>
      <author>
        <name>Broderick, Ryan C</name>
      </author>
      <author>
        <name>Sandler, Bryan J</name>
      </author>
      <author>
        <name>Doucet, Jay J</name>
      </author>
      <author>
        <name>Hu, Sandy R</name>
      </author>
      <author>
        <name>J., Brannon</name>
      </author>
      <author>
        <name>Murthy, Adhithi Narayana</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
    </item>
    <item>
      <title>Structural homology of myelin basic protein and muscarinic acetylcholine receptor: Significance in the pathogenesis of complex regional pain syndrome</title>
      <link>https://escholarship.org/uc/item/34z6j3dz</link>
      <description>Complex regional pain syndrome is an extremely painful condition that develops after trauma to a limb. Complex regional pain syndrome exhibits autoimmune features in part mediated by autoantibodies against muscarinic-2 acetylcholine (M2) receptor. The mechanisms underlying the M2 receptor involvement in complex regional pain syndrome remain obscure. Based on our recent work demonstrating that limb nerve trauma releases a potent proalgesic, immunodominant myelin basic protein fragment, our present sequence database analyses reveal an unexpected and previously undescribed structural homology of the proalgesic myelin basic protein fragment with the M2 receptor. As both complex regional pain syndrome and the proalgesic myelin basic protein activity are prevalent in females, this myelin basic protein/M2 homology presents an inviting hypothesis explaining the mechanisms of autoimmune pathogenesis and sexual dimorphism that underlies vulnerability toward developing complex regional pain...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/34z6j3dz</guid>
      <pubDate>Tue, 7 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Shubayev, Veronica I</name>
      </author>
      <author>
        <name>Strongin, Alex Y</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Corrigendum: Intrathecal drug delivery: Advances and applications in the management of chronic pain patient</title>
      <link>https://escholarship.org/uc/item/00q8d1v3</link>
      <description>[This corrects the article DOI: 10.3389/fpain.2022.900566.].</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/00q8d1v3</guid>
      <pubDate>Tue, 7 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>De Andres, Jose</name>
      </author>
      <author>
        <name>Hayek, Salim</name>
      </author>
      <author>
        <name>Perruchoud, Christophe</name>
      </author>
      <author>
        <name>Lawrence, Melinda M</name>
      </author>
      <author>
        <name>Reina, Miguel Angel</name>
      </author>
      <author>
        <name>De Andres-Serrano, Carmen</name>
      </author>
      <author>
        <name>Rubio-Haro, Ruben</name>
      </author>
      <author>
        <name>Hunt, Mathew</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety</title>
      <link>https://escholarship.org/uc/item/9z83z2dn</link>
      <description>Chronic pain continues to be a significant global burden despite the availability of a variety of nonpharmacologic and pharmacologic treatment options. Thus, there is a need for new analgesics with novel mechanisms of action. In this regard, antibodies directed against nerve growth factor (NGF-Abs) are a new class of agents in development for the treatment of chronic pain conditions such as osteoarthritis and chronic low-back pain. This comprehensive narrative review summarizes evidence supporting pronociceptive functions for NGF that include contributing to peripheral and central sensitization through tropomyosin receptor kinase A activation and stimulation of local neuronal sprouting. The potential role of NGF in osteoarthritis and chronic low-back pain signaling is also examined to provide a mechanistic basis for the observed efficacy of NGF-Abs in clinical trials of these particular pain states. Finally, the safety profile of NGF-Abs in terms of common adverse events, joint...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9z83z2dn</guid>
      <pubDate>Sat, 4 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Schmelz, Martin</name>
      </author>
      <author>
        <name>Mantyh, Patrick</name>
      </author>
      <author>
        <name>Malfait, Anne-Marie</name>
      </author>
      <author>
        <name>Farrar, John</name>
      </author>
      <author>
        <name>Yaksh, Tony</name>
      </author>
      <author>
        <name>Tive, Leslie</name>
      </author>
      <author>
        <name>Viktrup, Lars</name>
      </author>
    </item>
    <item>
      <title>Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid</title>
      <link>https://escholarship.org/uc/item/9x08v2mz</link>
      <description>&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; In recent research, orally administered cannabidiol (CBD) showed a relatively high incidence of somnolence in a pediatric population. Previous work has suggested that when CBD is exposed to an acidic environment, it degrades to Δ&lt;sup&gt;9&lt;/sup&gt;-tetrahydrocannabinol (THC) and other psychoactive cannabinoids. To gain a better understanding of quantitative exposure, we completed an &lt;i&gt;in vitro&lt;/i&gt; study by evaluating the formation of psychoactive cannabinoids when CBD is exposed to simulated gastric fluid (SGF). &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; Materials included synthetic CBD, Δ&lt;sup&gt;8&lt;/sup&gt;-THC, and Δ&lt;sup&gt;9&lt;/sup&gt;-THC. Linearity was demonstrated for each component over the concentration range used in this study. CBD was spiked into media containing 1% sodium dodecyl sulfate (SDS). Samples were analyzed using chromatography with UV and mass spectrometry detection. An assessment time of 3 h was chosen as representative of the maximal duration of exposure to gastric fluid....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9x08v2mz</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Merrick, John</name>
      </author>
      <author>
        <name>Lane, Brian</name>
      </author>
      <author>
        <name>Sebree, Terri</name>
      </author>
      <author>
        <name>Yaksh, Tony</name>
      </author>
      <author>
        <name>O'Neill, Carol</name>
      </author>
      <author>
        <name>Banks, Stan L</name>
      </author>
    </item>
    <item>
      <title>Characterization of Effect of Repeated Bolus or Continuous Intrathecal Infusion of Morphine on Spinal Mass Formation in the Dog</title>
      <link>https://escholarship.org/uc/item/7dh6k4fr</link>
      <description>BACKGROUND: We determined whether intrathecally delivering the same daily dose of morphine (MS) at a fixed concentration of 25 mg/mL by periodic boluses versus continuous infusion would reduce intrathecal mass (IMs) formation in dogs.
METHODS: Adult dogs (hound cross, n = 32) were implanted with intrathecal catheters connected to SynchroMed II infusion pumps. Animals were randomly assigned to receive infusion of 0.48 mL/day of saline or MS dosing (12 mg/day at 25 mg/mL) as boluses: x1 (q24hour), x2 (q12hour), x4 (q6hour), or x8 (q3hour) given at the rate of 1000 μL/hour, or as a continuous infusion (25 mg/mL/20 μL/hour).
RESULTS: With IT saline, minimal pathology was noted. In contrast, animals receiving morphine displayed spinally compressing durally derived masses with the maximal cross-sectional area being greatest near the catheter tip. Histopathology showed that IMs consisted of fibroblasts in a collagen (type 1) matrix comprised of newly formed collagen near the catheter...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7dh6k4fr</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hildebrand, Keith R</name>
      </author>
      <author>
        <name>Page, Linda M</name>
      </author>
      <author>
        <name>Billstrom, Tina M</name>
      </author>
      <author>
        <name>Steinauer, Joanne J</name>
      </author>
      <author>
        <name>Eddinger, Kelly A</name>
      </author>
      <author>
        <name>Arjomand, Shervin</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Unintended consequences of COVID-19 safety measures on patients with chronic knee pain forced to defer joint replacement surgery</title>
      <link>https://escholarship.org/uc/item/43m7171s</link>
      <description>In recent months, with the emergence of the COVID-19 pandemic, the American College of Surgeons and the U.S. Centers for Disease Control and Prevention officially recommended the delay of nonemergency procedures until the public health crisis is resolved. Deferring elective joint replacement surgeries for an unknown period is likely to decrease the incidence of infection with SARS-CoV-2 but is likely to have detrimental effects in individuals suffering from chronic knee pain. These detrimental effects extend beyond the discomfort of osteoarthritis (OA) and the inconvenience of rescheduling surgery. Disabling pain is a driving factor for individuals to seek medical intervention, including pharmacological palliative treatment and surgical procedures. The need for surgical intervention due to chronic pain as for knee and hip replacement is now put on hold indefinitely because access to surgical care has been limited. Although a moderate delay in surgical intervention may not produce...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/43m7171s</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Cisternas, Alvaro F</name>
      </author>
      <author>
        <name>Ramachandran, Roshni</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
      <author>
        <name>Nahama, Alexis</name>
      </author>
    </item>
    <item>
      <title>Sex differences in neuroimmune and glial mechanisms of pain</title>
      <link>https://escholarship.org/uc/item/42x5j3nz</link>
      <description>ABSTRACT: Pain is the primary motivation for seeking medical care. Although pain may subside as inflammation resolves or an injury heals, it is increasingly evident that persistency of the pain state can occur with significant regularity. Chronic pain requires aggressive management to minimize its physiological consequences and diminish its impact on quality of life. Although opioids commonly are prescribed for intractable pain, concerns regarding reduced efficacy, as well as risks of tolerance and dependence, misuse, diversion, and overdose mortality rates limit their utility. Advances in development of nonopioid interventions hinge on our appreciation of underlying mechanisms of pain hypersensitivity. For instance, the contributory role of immunity and the associated presence of autoimmune syndromes has become of particular interest. Males and females exhibit fundamental differences in innate and adaptive immune responses, some of which are present throughout life, whereas others...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/42x5j3nz</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gregus, Ann M</name>
      </author>
      <author>
        <name>Levine, Ian S</name>
      </author>
      <author>
        <name>Eddinger, Kelly A</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
      <author>
        <name>Buczynski, Matthew W</name>
      </author>
    </item>
    <item>
      <title>Non-invasive evaluation of Achilles tendon and its enthesis using ultrashort echo time adiabatic T1ρ (UTE-Adiab-T1ρ) magnetic resonance imaging (MRI) in psoriatic arthritis</title>
      <link>https://escholarship.org/uc/item/104198k7</link>
      <description>PURPOSE: This cross-sectional study investigates the utility of the quantitative ultrashort echo time (UTE) adiabatic T&lt;sub&gt;1ρ&lt;/sub&gt; (UTE-Adiab-T&lt;sub&gt;1ρ&lt;/sub&gt;) magnetic resonance imaging (MRI) in detecting potential differences in Achilles tendons and entheses of patients with psoriatic arthritis disease (PsA) compared with asymptomatic volunteers.
MATERIAL AND METHOD: The Achilles tendons of forty-four PsA patients (59&amp;nbsp;±&amp;nbsp;15&amp;nbsp;years old, 38&amp;nbsp;% female) and thirty-seven asymptomatic volunteers (32&amp;nbsp;±&amp;nbsp;10&amp;nbsp;years old, 51&amp;nbsp;% female) were scanned on a 3&amp;nbsp;T clinical scanner in the sagittal plane using a 3-inch surface coil. The 3D UTE-Adiab-T&lt;sub&gt;1ρ&lt;/sub&gt; sequences with fat saturation (FS) were used to measure UTE-Adiab-T&lt;sub&gt;1ρ&lt;/sub&gt;. Tenderness of the tendons, the SF-12 health survey, and visual analog scale (VAS) were recorded for the patients. The Kruskal Wallis test was used to examine the differences in UTE-Adiab-T1&lt;sub&gt;ρ&lt;/sub&gt; values between...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/104198k7</guid>
      <pubDate>Mon, 23 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Moazamian, Dina</name>
        <uri>https://orcid.org/0000-0002-8815-4535</uri>
      </author>
      <author>
        <name>Mohammadi, Hamidreza Shaterian</name>
      </author>
      <author>
        <name>Athertya, Jiyo</name>
        <uri>https://orcid.org/0000-0002-0866-1052</uri>
      </author>
      <author>
        <name>Daskareh, Mahyar</name>
      </author>
      <author>
        <name>Ma, Yajun</name>
        <uri>https://orcid.org/0000-0003-0830-9232</uri>
      </author>
      <author>
        <name>Guma, Monica</name>
      </author>
      <author>
        <name>Covey, Dana C</name>
        <uri>https://orcid.org/0000-0002-4023-6304</uri>
      </author>
      <author>
        <name>Yaksh, Tony</name>
      </author>
      <author>
        <name>Singh, Abha</name>
      </author>
      <author>
        <name>Kavanaugh, Arthur</name>
      </author>
      <author>
        <name>Chung, Christine B</name>
      </author>
      <author>
        <name>Du, Jiang</name>
      </author>
      <author>
        <name>Chang, Eric Y</name>
      </author>
      <author>
        <name>Jerban, Saeed</name>
        <uri>https://orcid.org/0000-0001-6450-2892</uri>
      </author>
    </item>
    <item>
      <title>Role of Toll-like receptor 4 signaling in mast cell-mediated migraine pain pathway</title>
      <link>https://escholarship.org/uc/item/3m00h4s5</link>
      <description>Degranulation of meningeal mast cells leading to the sensitization of trigeminal vascular afferent processing is believed to be one of the mechanisms underlying the migraine pain pathway. Recent work suggests that Toll-like receptor 4 (TLR4) may be involved in signaling states of central sensitization. Using a murine model of light aversion produced by compound 48/80 (2 mg/kg, intraperitoneal) mast cell degranulation, employed as a surrogate marker for photophobia observed in migraineurs, we examined the role of TLR4 in migraine-like behavior and neuronal activation. Using a two-chambered light/dark box, we found that compound 48/80 administration in male and female C57Bl/6 mice produced light aversion lasting up to 2 h, and that pre-treatment with sumatriptan (1 mg/kg, i.p.) reliably prevented this effect. Genetic deletion and pharmacological blockade of TLR4 with TAK-242 (3 mg/kg, i.p.) reversed the light aversive effects of compound 48/80 in males but not in females. Assessing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3m00h4s5</guid>
      <pubDate>Fri, 20 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ramachandran, Roshni</name>
      </author>
      <author>
        <name>Wang, Zhenping</name>
      </author>
      <author>
        <name>Saavedra, Christian</name>
      </author>
      <author>
        <name>DiNardo, Anna</name>
      </author>
      <author>
        <name>Corr, Maripat</name>
      </author>
      <author>
        <name>Powell, Susan B</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Language Dominance and Cultural Identity Predict Variation in Self-Reported Personality in English and Spanish Among Hispanic/Latino Bilingual Adults</title>
      <link>https://escholarship.org/uc/item/5wt584wz</link>
      <description>Language is a fundamental aspect of human culture that influences cognitive and perceptual processes. Prior evidence demonstrates personality self-report can vary across multilingual persons' language contexts. We assessed how cultural identification, language dominance, or both dynamically influence bilingual respondents' self-conception, via self-reported personality, across English and Spanish contexts. During separate English and Spanish conditions, 133 Hispanic/Latino bilingual participants (70 female) completed the Big Five Inventory of personality. We used language use and acculturation surveys completed in both languages to calculate participants' relative language dominance and identification with U.S.-American and Hispanic culture. Participants reported higher levels of agreeableness, conscientiousness, and neuroticism in English relative to Spanish. Language dominance predicted cross-language differences in personality report, with higher extraversion reported in participants'...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5wt584wz</guid>
      <pubDate>Thu, 21 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gianola, Morgan</name>
      </author>
      <author>
        <name>Llabre, Maria M</name>
      </author>
      <author>
        <name>Losin, Elizabeth A Reynolds</name>
      </author>
    </item>
    <item>
      <title>EMG-projected MEG high-resolution source imaging of human motor execution: Brain-muscle coupling above movement frequencies</title>
      <link>https://escholarship.org/uc/item/9jk642vm</link>
      <description>Magnetoencephalography (MEG) is a non-invasive functional imaging technique for pre-surgical mapping. However, movement-related MEG functional mapping of primary motor cortex (M1) has been challenging in presurgical patients with brain lesions and sensorimotor dysfunction due to the large numbers of trials needed to obtain adequate signal to noise. Moreover, it is not fully understood how effective the brain communication is with the muscles at frequencies above the movement frequency and its harmonics. We developed a novel Electromyography (EMG)-projected MEG source imaging technique for localizing early-stage (-100 to 0 ms) M1 activity during ~l min recordings of left and right self-paced finger movements (~1 Hz). High-resolution MEG source images were obtained by projecting M1 activity towards the skin EMG signal without trial averaging. We studied delta (1-4 Hz), theta (4-7 Hz), alpha (8-12 Hz), beta (15-30 Hz), gamma (30-90 Hz), and upper-gamma (60-90 Hz) bands in 13 healthy...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9jk642vm</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Huang, Ming-Xiong</name>
      </author>
      <author>
        <name>Harrington, Deborah L</name>
        <uri>https://orcid.org/0000-0001-9658-9080</uri>
      </author>
      <author>
        <name>Angeles-Quinto, Annemarie</name>
      </author>
      <author>
        <name>Ji, Zhengwei</name>
      </author>
      <author>
        <name>Robb-Swan, Ashley</name>
      </author>
      <author>
        <name>Huang, Charles W</name>
      </author>
      <author>
        <name>Shen, Qian</name>
      </author>
      <author>
        <name>Hansen, Hayden</name>
      </author>
      <author>
        <name>Baumgartner, Jared</name>
      </author>
      <author>
        <name>Hernandez-Lucas, Jaqueline</name>
      </author>
      <author>
        <name>Nichols, Sharon</name>
      </author>
      <author>
        <name>Jacobus, Joanna</name>
      </author>
      <author>
        <name>Song, Tao</name>
      </author>
      <author>
        <name>Lerman, Imanuel</name>
        <uri>https://orcid.org/0000-0002-6564-7222</uri>
      </author>
      <author>
        <name>Bazhenov, Maksim</name>
      </author>
      <author>
        <name>Krishnan, Giri P</name>
      </author>
      <author>
        <name>Baker, Dewleen G</name>
        <uri>https://orcid.org/0000-0002-1736-9838</uri>
      </author>
      <author>
        <name>Rao, Ramesh</name>
        <uri>https://orcid.org/0000-0002-6523-0208</uri>
      </author>
      <author>
        <name>Lee, Roland R</name>
      </author>
    </item>
    <item>
      <title>Self-regulated analgesia in males but not females is mediated by endogenous opioids</title>
      <link>https://escholarship.org/uc/item/83f4q2nr</link>
      <description>Converging lines of preclinical and clinical research indicate that females, in stark contrast to males, display an increased prevalence of chronic pain. Females also demonstrate weaker analgesic efficacy in response to opioid therapies when compared with males. These sex-specific differences may be driven by dimorphic endogenous opioidergic responses. In rodent models, analgesia exhibited in males but not females was reversed by inhibiting endogenous opioidergic reception. In humans, the sex-specific endogenous system(s) supporting the direct attenuation of evoked pain has not been identified. To determine whether opioidergic blockade reverses self-regulated analgesia in males as compared to females, the present study combined two operationally analogous clinical trials (&lt;i&gt;n&lt;/i&gt; = 98; 51 females and 47 males). In a double-blinded, counterbalanced study involving healthy (&lt;i&gt;n&lt;/i&gt; = 39) and chronic low back pain (&lt;i&gt;n&lt;/i&gt; = 59) populations, a high-dose naloxone (μ-, κ-, δ-opioid...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/83f4q2nr</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Dean, Jon G</name>
      </author>
      <author>
        <name>Reyes, Mikaila</name>
      </author>
      <author>
        <name>Oliva, Valeria</name>
      </author>
      <author>
        <name>Khatib, Lora</name>
      </author>
      <author>
        <name>Riegner, Gabriel</name>
      </author>
      <author>
        <name>Gonzalez, Nailea</name>
      </author>
      <author>
        <name>Posey, Grace</name>
      </author>
      <author>
        <name>Collier, Jason</name>
      </author>
      <author>
        <name>Birenbaum, Julia</name>
      </author>
      <author>
        <name>Chakravarthy, Krishnan</name>
      </author>
      <author>
        <name>Wells, Rebecca E</name>
      </author>
      <author>
        <name>Goodin, Burel</name>
      </author>
      <author>
        <name>Fillingim, Roger</name>
      </author>
      <author>
        <name>Zeidan, Fadel</name>
      </author>
    </item>
    <item>
      <title>Percutaneous auricular neuromodulation (nerve stimulation) for the treatment of pain following cholecystectomy and hernia repair: a randomized, double-masked, sham-controlled pilot study</title>
      <link>https://escholarship.org/uc/item/7kc5d6h5</link>
      <description>BACKGROUND: Percutaneous auricular nerve stimulation (neuromodulation) involves implanting electrodes around the ear and administering an electric current. A device is currently available within the USA cleared to treat symptoms from opioid withdrawal, and multiple reports suggest a possible postoperative analgesic effect. The current randomized controlled pilot study was undertaken to (1) determine the feasibility and optimize the protocol for a subsequent definitive clinical trial; and (2) estimate the treatment effect of auricular neuromodulation on postoperative pain and opioid consumption following two ambulatory surgical procedures.
METHODS: Within the recovery room following cholecystectomy or hernia repair, an auricular neuromodulation device (NSS-2 Bridge, Masimo, Irvine, California, USA) was applied. Participants were randomized to 5 days of either electrical stimulation or sham in a double-blinded fashion.
RESULTS: In the first 5 days, the median (IQR) pain level for...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7kc5d6h5</guid>
      <pubDate>Fri, 8 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ilfeld, Brian M</name>
        <uri>https://orcid.org/0000-0002-6144-3273</uri>
      </author>
      <author>
        <name>Abramson, Wendy B</name>
      </author>
      <author>
        <name>Alexander, Brenton</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>Sztain, Jacklynn F</name>
      </author>
      <author>
        <name>Said, Engy T</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Broderick, Ryan C</name>
      </author>
      <author>
        <name>Sandler, Bryan J</name>
      </author>
      <author>
        <name>Doucet, Jay J</name>
      </author>
      <author>
        <name>Adams, Laura M</name>
      </author>
      <author>
        <name>Abdullah, Baharin</name>
      </author>
      <author>
        <name>J, Brannon</name>
      </author>
      <author>
        <name>Finneran, John J</name>
      </author>
    </item>
    <item>
      <title>The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma</title>
      <link>https://escholarship.org/uc/item/6rc3f57r</link>
      <description>The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6rc3f57r</guid>
      <pubDate>Thu, 7 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Colapietro, Alessandro</name>
      </author>
      <author>
        <name>Yang, Peiying</name>
      </author>
      <author>
        <name>Rosetti, Alessandra</name>
      </author>
      <author>
        <name>Mancini, Andrea</name>
      </author>
      <author>
        <name>Vital, Flora</name>
      </author>
      <author>
        <name>Martellucci, Stefano</name>
        <uri>https://orcid.org/0000-0002-3952-3162</uri>
      </author>
      <author>
        <name>Marampon, Francesco</name>
      </author>
      <author>
        <name>Mattei, Vincenzo</name>
      </author>
      <author>
        <name>Gravina, Giovanni Luca</name>
      </author>
      <author>
        <name>Newman, Robert</name>
      </author>
      <author>
        <name>Festuccia, Claudio</name>
      </author>
    </item>
    <item>
      <title>The botanical drug PBI-05204, a supercritical CO&lt;sub&gt;2&lt;/sub&gt; extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma.</title>
      <link>https://escholarship.org/uc/item/6kt9v36h</link>
      <description>The botanical drug PBI-05204, a supercritical CO&lt;sub&gt;2&lt;/sub&gt; extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6kt9v36h</guid>
      <pubDate>Thu, 7 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Colapietro, Alessandro</name>
      </author>
      <author>
        <name>Yang, Peiying</name>
      </author>
      <author>
        <name>Rosetti, Alessandra</name>
      </author>
      <author>
        <name>Mancini, Andrea</name>
      </author>
      <author>
        <name>Vital, Flora</name>
      </author>
      <author>
        <name>Martellucci, Stefano</name>
        <uri>https://orcid.org/0000-0002-3952-3162</uri>
      </author>
      <author>
        <name>Marampon, Francesco</name>
      </author>
      <author>
        <name>Mattei, Vincenzo</name>
      </author>
      <author>
        <name>Gravina, Giovanni Luca</name>
      </author>
      <author>
        <name>Newman, Robert</name>
      </author>
      <author>
        <name>Festuccia, Claudio</name>
      </author>
    </item>
    <item>
      <title>MITOCHONDRIAL HOMEOSTASIS IN SCHWANN CELLS IS LINKED TO C-FIBER NEUROENERGETICS AND NEUROPATHIC PAIN</title>
      <link>https://escholarship.org/uc/item/0dz9q3zj</link>
      <description>MITOCHONDRIAL HOMEOSTASIS IN SCHWANN CELLS IS LINKED TO C-FIBER NEUROENERGETICS AND NEUROPATHIC PAIN</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0dz9q3zj</guid>
      <pubDate>Thu, 7 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Martellucci, Stefano</name>
        <uri>https://orcid.org/0000-0002-3952-3162</uri>
      </author>
      <author>
        <name>Heredia, Melissa</name>
      </author>
      <author>
        <name>Wang, Zixuan</name>
      </author>
      <author>
        <name>Whisenant, Thomas</name>
      </author>
      <author>
        <name>Strickland, Dudley</name>
      </author>
      <author>
        <name>Sanchez, Richard</name>
      </author>
      <author>
        <name>Pekkurnaz, Gulcin</name>
      </author>
      <author>
        <name>Zhang, Morgan</name>
      </author>
      <author>
        <name>Liu, NJ</name>
      </author>
      <author>
        <name>Asam, Kesava</name>
      </author>
      <author>
        <name>Aouizerat, Brad</name>
      </author>
      <author>
        <name>Ye, Yi</name>
      </author>
      <author>
        <name>Campana, Wendy</name>
      </author>
    </item>
    <item>
      <title>Surgery and Anesthesia Preoperative “Virtual Huddle”: A Pilot Trial to Enhance Communication across the Drape</title>
      <link>https://escholarship.org/uc/item/8g45v5b8</link>
      <description>OBJECTIVES: Effective communication between surgeons and anesthesiologists is critical for high-quality, safe, and efficient perioperative patient care. Despite widespread implementation of surgical safety checklists and time-outs, ineffective team communication remains a leading cause of patient safety events in the operating room. To promote effective communication, we conducted a pilot trial of a "virtual huddle" between anesthesiologists and surgeons.
METHODS: Attending anesthesiologists and surgeons at an academic medical center were recruited by email to participate in this feasibility trial. An electronic health record-based smartphone application was utilized to create secure group chats among trial participants the day before a surgery. Text notifications connected a surgeon/anesthesiologist pair in order to introduce colleagues, facilitate a preoperative virtual huddle, and enable open-ended, text message-based communication. A 5-point Likert scale-based survey with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8g45v5b8</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Goldhaber, Nicole H</name>
      </author>
      <author>
        <name>Reeves, J Jeffery</name>
      </author>
      <author>
        <name>Puri, Dhruv</name>
      </author>
      <author>
        <name>Berumen, Jennifer A</name>
      </author>
      <author>
        <name>Tran, Minh</name>
      </author>
      <author>
        <name>Clay, Brian J</name>
      </author>
      <author>
        <name>Longhurst, Christopher A</name>
      </author>
      <author>
        <name>Fergerson, Byron</name>
      </author>
    </item>
    <item>
      <title>Elevated C-Reactive Protein in Older Men With Chronic Pain: Association With Plasma Amyloid Levels and Hippocampal Volume</title>
      <link>https://escholarship.org/uc/item/1pc36997</link>
      <description>BACKGROUND: Chronic pain leads to tau accumulation and hippocampal atrophy, which may be moderated through inflammation. In older men, we examined associations of chronic pain with Alzheimer's disease (AD)-related plasma biomarkers and hippocampal volume as moderated by systemic inflammation.
METHODS: Participants were men without dementia. Chronic pain was defined as moderate-to-severe pain in 2+ study waves at average ages 56, 62, and 68. At age 68, we measured plasma amyloid-beta (Aβ42, n = 871), Aβ40 (n = 887), total tau (t-tau, n = 841), and neurofilament light chain (NfL, n = 915), and serum high-sensitivity C-reactive protein (hs-CRP, n = 968), a marker of systemic inflammation. A subgroup underwent structural MRI to measure hippocampal volume (n = 385). Analyses adjusted for medical morbidities, depressive symptoms, and opioid use.
RESULTS: Chronic pain was related to higher Aβ40 (β = 0.25, p = .009), but hs-CRP was unrelated to AD-related biomarkers (ps &amp;gt; .05). There...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1pc36997</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Bell, Tyler R</name>
        <uri>https://orcid.org/0000-0001-5702-5995</uri>
      </author>
      <author>
        <name>Franz, Carol E</name>
        <uri>https://orcid.org/0000-0002-8987-1755</uri>
      </author>
      <author>
        <name>Thomas, Kelsey R</name>
      </author>
      <author>
        <name>Williams, McKenna E</name>
      </author>
      <author>
        <name>Eyler, Lisa T</name>
        <uri>https://orcid.org/0000-0002-7783-8798</uri>
      </author>
      <author>
        <name>Lerman, Imanuel</name>
        <uri>https://orcid.org/0000-0002-6564-7222</uri>
      </author>
      <author>
        <name>Fennema-Notestine, Christine</name>
      </author>
      <author>
        <name>Puckett, Olivia K</name>
      </author>
      <author>
        <name>Dorros, Stephen M</name>
      </author>
      <author>
        <name>Panizzon, Matthew S</name>
        <uri>https://orcid.org/0000-0002-6449-2097</uri>
      </author>
      <author>
        <name>Pearce, Rahul C</name>
      </author>
      <author>
        <name>Hagler, Donald J</name>
      </author>
      <author>
        <name>Lyons, Michael J</name>
      </author>
      <author>
        <name>Elman, Jeremy A</name>
      </author>
      <author>
        <name>Kremen, William S</name>
      </author>
    </item>
    <item>
      <title>Identification and Characterization of Synthetic Nicotine Product Promotion and Sales on Instagram Using Natural Language Processing</title>
      <link>https://escholarship.org/uc/item/9km4j1cr</link>
      <description>INTRODUCTION: There has been a rapid proliferation of synthetic nicotine products in recent years, despite newly established regulatory authority and limited research into its health risks. Previous research has implicated social media platforms as an avenue for nicotine product unregulated sales. Yet, little is known about synthetic nicotine product content on social media. We utilized natural language processing to characterize the sales of synthetic nicotine products on Instagram.
METHODS: We collected Instagram posts by querying Instagram hashtags (eg, "#tobaccofreenicotine) related to synthetic nicotine. Using Bidirectional Encoder Representations from Transformers, collected posts were categorized into thematically related topic clusters. Posts within topic clusters relevant to study aims were then manually annotated for variables related to promotion and selling (eg, cost discussion, contact information for offline sales).
RESULTS: A total of 7425 unique posts were collected...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9km4j1cr</guid>
      <pubDate>Mon, 4 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Shah, Neal A</name>
      </author>
      <author>
        <name>Li, Zhuoran</name>
      </author>
      <author>
        <name>McMann, Tiana</name>
      </author>
      <author>
        <name>Calac, Alec J</name>
      </author>
      <author>
        <name>Le, Nicolette</name>
      </author>
      <author>
        <name>Nali, Matthew C</name>
        <uri>https://orcid.org/0000-0002-0565-8202</uri>
      </author>
      <author>
        <name>Cuomo, Raphael E</name>
        <uri>https://orcid.org/0000-0002-8179-0619</uri>
      </author>
      <author>
        <name>Mackey, Tim K</name>
      </author>
    </item>
    <item>
      <title>Detection and Characterization of Online Substance Use Discussions Among Gamers: Qualitative Retrospective Analysis of Reddit r/StopGaming Data.</title>
      <link>https://escholarship.org/uc/item/76w1q5m1</link>
      <description>BACKGROUND: Video games have rapidly become mainstream in recent decades, with over half of the US population involved in some form of digital gaming. However, concerns regarding the potential harms of excessive, disordered gaming have also risen. Internet gaming disorder (IGD) has been proposed as a tentative psychiatric disorder that requires further study by the American Psychological Association (APA) and is recognized as a behavioral addiction by the World Health Organization. Substance use among gamers has also become a concern, with caffeinated or energy drinks and prescription stimulants commonly used for performance enhancement. OBJECTIVE: This study aimed to identify substance use patterns and health-related concerns among gamers among a population of Reddit users. METHODS: We used the public streaming Reddit application programming interface to collect and analyze all posts from the popular subreddit, r/StopGaming. From this corpus of posts, we filtered the dataset...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/76w1q5m1</guid>
      <pubDate>Sat, 2 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Le, Nicolette</name>
      </author>
      <author>
        <name>McMann, Tiana</name>
      </author>
      <author>
        <name>Yang, Luning</name>
      </author>
      <author>
        <name>Li, Zhuoran</name>
      </author>
      <author>
        <name>Cuomo, Raphael</name>
      </author>
      <author>
        <name>Mackey, Tim</name>
      </author>
    </item>
    <item>
      <title>Pain mechanisms in the transgender individual: a review</title>
      <link>https://escholarship.org/uc/item/5xx2x7h4</link>
      <description>Specific Aim: Provide an overview of the literature addressing major areas pertinent to pain in transgender persons and to identify areas of primary relevance for future research.
Methods: A team of scholars that have previously published on different areas of related research met periodically though zoom conferencing between April 2021 and February 2023 to discuss relevant literature with the goal of providing an overview on the incidence, phenotype, and mechanisms of pain in transgender patients. Review sections were written after gathering information from systematic literature searches of published or publicly available electronic literature to be compiled for publication as part of a topical series on gender and pain in the Frontiers in Pain Research.
Results: While transgender individuals represent a significant and increasingly visible component of the population, many researchers and clinicians are not well informed about the diversity in gender identity, physiology, hormonal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5xx2x7h4</guid>
      <pubDate>Sat, 26 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Anger, Jennifer T</name>
      </author>
      <author>
        <name>Case, Laura K</name>
        <uri>https://orcid.org/0000-0003-3730-2451</uri>
      </author>
      <author>
        <name>Baranowski, Andrew P</name>
      </author>
      <author>
        <name>Berger, Ardin</name>
      </author>
      <author>
        <name>Craft, Rebecca M</name>
      </author>
      <author>
        <name>Damitz, Lyn Ann</name>
      </author>
      <author>
        <name>Gabriel, Rodney</name>
      </author>
      <author>
        <name>Harrison, Tracy</name>
      </author>
      <author>
        <name>Kaptein, Kirsten</name>
      </author>
      <author>
        <name>Lee, Sanghee</name>
      </author>
      <author>
        <name>Murphy, Anne Z</name>
      </author>
      <author>
        <name>Said, Engy</name>
        <uri>https://orcid.org/0000-0002-7897-1670</uri>
      </author>
      <author>
        <name>Smith, Stacey Abigail</name>
      </author>
      <author>
        <name>Thomas, David A</name>
      </author>
      <author>
        <name>del C. Valdés Hernández, Maria</name>
      </author>
      <author>
        <name>Trasvina, Victor</name>
      </author>
      <author>
        <name>Wesselmann, Ursula</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
    </item>
    <item>
      <title>Correction: Gravina et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers 2022, 14, 289</title>
      <link>https://escholarship.org/uc/item/12t989qm</link>
      <description>In the original publication [...].</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/12t989qm</guid>
      <pubDate>Thu, 24 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gravina, Giovanni Luca</name>
      </author>
      <author>
        <name>Colapietro, Alessandro</name>
      </author>
      <author>
        <name>Mancini, Andrea</name>
      </author>
      <author>
        <name>Rossetti, Alessandra</name>
      </author>
      <author>
        <name>Martellucci, Stefano</name>
        <uri>https://orcid.org/0000-0002-3952-3162</uri>
      </author>
      <author>
        <name>Ventura, Luca</name>
      </author>
      <author>
        <name>Di Franco, Martina</name>
      </author>
      <author>
        <name>Marampon, Francesco</name>
      </author>
      <author>
        <name>Mattei, Vincenzo</name>
      </author>
      <author>
        <name>Biordi, Leda Assunta</name>
      </author>
      <author>
        <name>Otterlei, Marit</name>
      </author>
      <author>
        <name>Festuccia, Claudio</name>
      </author>
    </item>
    <item>
      <title>Loss of cAMP Signaling in CD11c Immune Cells Protects Against Diet-Induced Obesity.</title>
      <link>https://escholarship.org/uc/item/8cm1954j</link>
      <description>In obesity, CD11c+ innate immune cells are recruited to adipose tissue and create an inflammatory state that causes both insulin and catecholamine resistance. We found that ablation of Gnas, the gene that encodes Gαs, in CD11c expressing cells protects mice from obesity, glucose intolerance, and insulin resistance. Transplantation studies showed that the lean phenotype was conferred by bone marrow-derived cells and did not require adaptive immunity. Loss of cAMP signaling was associated with increased adipose tissue norepinephrine and cAMP signaling, and prevention of catecholamine resistance. The adipose tissue had reduced expression of catecholamine transport and degradation enzymes, suggesting that the elevated norepinephrine resulted from decreased catabolism. Collectively, our results identified an important role for cAMP signaling in CD11c+ innate immune cells in whole-body metabolism by controlling norepinephrine levels in white adipose tissue, modulating catecholamine-induced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8cm1954j</guid>
      <pubDate>Tue, 10 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Zeng, Liping</name>
      </author>
      <author>
        <name>Herdman, D Scott</name>
      </author>
      <author>
        <name>Lee, Sung Min</name>
      </author>
      <author>
        <name>Tao, Ailin</name>
      </author>
      <author>
        <name>Das, Manasi</name>
      </author>
      <author>
        <name>Bertin, Samuel</name>
      </author>
      <author>
        <name>Eckmann, Lars</name>
      </author>
      <author>
        <name>Mahata, Sushil K</name>
        <uri>https://orcid.org/0000-0002-9154-0787</uri>
      </author>
      <author>
        <name>Wu, Panyisha</name>
      </author>
      <author>
        <name>Hara, Miki</name>
      </author>
      <author>
        <name>Byun, Ji-Won</name>
      </author>
      <author>
        <name>Devulapalli, Shwetha</name>
      </author>
      <author>
        <name>Patel, Hemal H</name>
        <uri>https://orcid.org/0000-0001-6722-9625</uri>
      </author>
      <author>
        <name>Molina, Anthony JA</name>
        <uri>https://orcid.org/0000-0002-5786-4622</uri>
      </author>
      <author>
        <name>Osborn, Olivia</name>
      </author>
      <author>
        <name>Corr, Maripat</name>
      </author>
      <author>
        <name>Raz, Eyal</name>
      </author>
      <author>
        <name>Webster, Nicholas JG</name>
        <uri>https://orcid.org/0000-0002-3827-5750</uri>
      </author>
    </item>
    <item>
      <title>Best Practice Alerts Informed by Inpatient Opioid Intake to Reduce Opioid Prescribing after Surgery (PRIOR): A Cluster Randomized Multiple Crossover Trial</title>
      <link>https://escholarship.org/uc/item/20v0t4qx</link>
      <description>BACKGROUND: Overprescription of opioids after surgery remains common. Residual and unnecessarily prescribed opioids can provide a reservoir for nonmedical use. This study therefore tested the hypothesis that a decision-support tool embedded in electronic health records guides clinicians to prescribe fewer opioids at discharge after inpatient surgery.
METHODS: This study included 21,689 surgical inpatient discharges in a cluster randomized multiple crossover trial from July 2020 to June 2021 in four Colorado hospitals. Hospital-level clusters were randomized to alternating 8-week periods during which an electronic decision-support tool recommended tailored discharge opioid prescriptions based on previous inpatient opioid intake. During active alert periods, the alert was displayed to clinicians when the proposed opioid prescription exceeded recommended amounts. No alerts were displayed during inactive periods. Carryover effects were mitigated by including 4-week washout periods....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/20v0t4qx</guid>
      <pubDate>Fri, 16 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Rolfzen, Megan L</name>
      </author>
      <author>
        <name>Wick, Abraham</name>
      </author>
      <author>
        <name>Mascha, Edward J</name>
      </author>
      <author>
        <name>Shah, Karan</name>
      </author>
      <author>
        <name>Krause, Martin</name>
      </author>
      <author>
        <name>Fernandez-Bustamante, Ana</name>
      </author>
      <author>
        <name>Kutner, Jean S</name>
      </author>
      <author>
        <name>Ho, P Michael</name>
      </author>
      <author>
        <name>Sessler, Daniel I</name>
      </author>
      <author>
        <name>Bartels, Karsten</name>
      </author>
    </item>
    <item>
      <title>A retrospective study of the effects of a vasopressor bolus on systolic slope (dP/dt) and dynamic arterial elastance (Eadyn)</title>
      <link>https://escholarship.org/uc/item/37m1f21w</link>
      <description>BackgroundTo enhance the utility of functional hemodynamic monitoring, the variables systolic slope (dP/dt) and dynamic arterial elastance (Eadyn) are calculated by the Hypotension Prediction Index (HPI) Acumen® Software. This study was designed to characterize the effects of phenylephrine and ephedrine on dP/dt and Eadyn.MethodsThis was a retrospective, non-randomized analysis of data collected during two clinical studies. All patients required intra-operative controlled mechanical ventilation and had an indwelling radial artery catheter connected to an Acumen IQ sensor. Raw arterial pressure waveform data was downloaded from the patient monitor and all hemodynamic measurements were calculated off-line. The anesthetic record was reviewed for bolus administrations of either phenylephrine or ephedrine. Cardiovascular variables prior to drug administration were compared to those following vasopressor administrations. The primary outcome was the difference for dP/dt and Eadyn at...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/37m1f21w</guid>
      <pubDate>Sat, 10 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Abdallah, Alexa C</name>
      </author>
      <author>
        <name>Song, Sang H</name>
      </author>
      <author>
        <name>Fleming, Neal W</name>
        <uri>https://orcid.org/0000-0002-4602-5903</uri>
      </author>
    </item>
    <item>
      <title>Non-invasive ventral cervical magnetoneurography as a proxy of in vivo lipopolysaccharide-induced inflammation</title>
      <link>https://escholarship.org/uc/item/3z09f01w</link>
      <description>Maintenance of autonomic homeostasis is continuously calibrated by sensory fibers of the vagus nerve and sympathetic chain that convey compound action potentials (CAPs) to the central nervous system. Lipopolysaccharide (LPS) intravenous challenge reliably elicits a robust inflammatory response that can resemble systemic inflammation and acute endotoxemia. Here, we administered LPS intravenously in nine healthy subjects while recording ventral cervical magnetoneurography (vcMNG)-derived CAPs at&amp;nbsp;the rostral Right Nodose Ganglion (RNG) and the&amp;nbsp;caudal Right Carotid Artery (RCA) with optically pumped magnetometers (OPM). We observed vcMNG RNG and RCA neural firing rates that tracked changes in TNF-α levels in the systemic circulation. Further, endotype subgroups based on high and low IL-6 responders segregate RNG CAP frequency (at 30-120 min) and based on high and low IL-10 response discriminate RCA CAP frequency (at 0-30 min). These vcMNG tools may enhance understanding...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3z09f01w</guid>
      <pubDate>Sat, 3 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Bu, Yifeng</name>
      </author>
      <author>
        <name>Burks, Jamison</name>
      </author>
      <author>
        <name>Yang, Kun</name>
      </author>
      <author>
        <name>Prince, Jacob</name>
      </author>
      <author>
        <name>Borna, Amir</name>
      </author>
      <author>
        <name>Coe, Christopher L</name>
      </author>
      <author>
        <name>Simmons, Alan</name>
      </author>
      <author>
        <name>Tu, Xin M</name>
      </author>
      <author>
        <name>Baker, Dewleen</name>
        <uri>https://orcid.org/0000-0002-1736-9838</uri>
      </author>
      <author>
        <name>Kimball, Donald</name>
      </author>
      <author>
        <name>Rao, Ramesh</name>
        <uri>https://orcid.org/0000-0002-6523-0208</uri>
      </author>
      <author>
        <name>Shah, Vishal</name>
      </author>
      <author>
        <name>Huang, Mingxiong</name>
      </author>
      <author>
        <name>Schwindt, Peter</name>
      </author>
      <author>
        <name>Coleman, Todd P</name>
      </author>
      <author>
        <name>Lerman, Imanuel</name>
        <uri>https://orcid.org/0000-0002-6564-7222</uri>
      </author>
    </item>
    <item>
      <title>Machine Learning-Based Models Predicting Outpatient Surgery End Time and Recovery Room Discharge at an Ambulatory Surgery Center</title>
      <link>https://escholarship.org/uc/item/95v91553</link>
      <description>BACKGROUND: Days before surgery, add-ons may be scheduled to fill unused surgical block time at an outpatient surgery center. At times, outpatient surgery centers have time limitations for end of block time and discharge from the postanesthesia care unit (PACU). The objective of our study was to develop machine learning models that predicted the following composite outcome: (1) surgery finished by end of operating room block time and (2) patient was discharged by end of recovery room nursing shift. We compared various machine learning models to logistic regression. By evaluating various performance metrics, including F1 scores, we hypothesized that models using ensemble learning will be superior to logistic regression.
METHODS: Data were collected from patients at an ambulatory surgery center. The primary outcome measurement was determined to have a value of 1 (versus 0) if they met both criteria: (1) surgery ends by 5 pm and (2) patient is discharged from the recovery room by...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/95v91553</guid>
      <pubDate>Fri, 2 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Harjai, Bhavya</name>
      </author>
      <author>
        <name>Simpson, Sierra</name>
      </author>
      <author>
        <name>Goldhaber, Nicole</name>
      </author>
      <author>
        <name>Curran, Brian P</name>
      </author>
      <author>
        <name>Waterman, Ruth S</name>
      </author>
    </item>
    <item>
      <title>The California Cognitive Assessment Battery (CCAB)</title>
      <link>https://escholarship.org/uc/item/5621q941</link>
      <description>Introduction: We are developing the California Cognitive Assessment Battery (CCAB) to provide neuropsychological assessments to patients who lack test access due to cost, capacity, mobility, and transportation barriers.
Methods: The CCAB consists of 15 non-verbal and 17 verbal subtests normed for telemedical assessment. The CCAB runs on calibrated tablet computers over cellular or Wi-Fi connections either in a laboratory or in participants' homes. Spoken instructions and verbal stimuli are delivered through headphones using naturalistic text-to-speech voices. Verbal responses are scored in real time and recorded and transcribed offline using consensus automatic speech recognition which combines the transcripts from seven commercial ASR engines to produce timestamped transcripts more accurate than those of any single ASR engine. The CCAB is designed for supervised self-administration using a web-browser application, the Examiner. The Examiner permits examiners to record observations,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5621q941</guid>
      <pubDate>Fri, 2 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Woods, David</name>
      </author>
      <author>
        <name>Pebler, Peter</name>
      </author>
      <author>
        <name>Johnson, David K</name>
        <uri>https://orcid.org/0000-0003-3670-8054</uri>
      </author>
      <author>
        <name>Herron, Timothy</name>
      </author>
      <author>
        <name>Hall, Kat</name>
      </author>
      <author>
        <name>Blank, Mike</name>
      </author>
      <author>
        <name>Geraci, Kristi</name>
      </author>
      <author>
        <name>Williams, Garrett</name>
      </author>
      <author>
        <name>Chok, Jas</name>
      </author>
      <author>
        <name>Lwi, Sandy</name>
      </author>
      <author>
        <name>Curran, Brian</name>
      </author>
      <author>
        <name>Schendel, Krista</name>
      </author>
      <author>
        <name>Spinelli, Maria</name>
      </author>
      <author>
        <name>Baldo, Juliana</name>
      </author>
    </item>
    <item>
      <title>Obesity and outcomes in patients undergoing upper airway surgery for obstructive sleep apnea</title>
      <link>https://escholarship.org/uc/item/4s0872q6</link>
      <description>OBJECTIVE: Obesity is frequently debated as a factor associated with increased postoperative complications. Specifically, upper airway surgeries for obstructive sleep apnea (OSA), a common comorbidity among obese patients, may be complicated by obesity's impact on intraoperative ventilation. The aim of this retrospective study was to analyze the association of various degrees of obesity with postoperative outcomes in patients undergoing surgery for OSA.
METHODS: The American College of Surgeons National Surgical Quality Improvement database between 2015 and 2019 was used to create a sample of patients diagnosed with OSA who underwent uvulopalatopharyngoplasty, tracheotomy, and surgeries at the base of tongue, maxilla, palate, or nose/turbinate. Inverse probability-weighted logistic regression and unadjusted multivariable logistic regression were used to compare outcomes of non-obese and obesity class 1, class 2, and class 3 groups (World Health Organization classification). Primary...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4s0872q6</guid>
      <pubDate>Fri, 2 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Du, Austin L</name>
        <uri>https://orcid.org/0000-0003-0313-0153</uri>
      </author>
      <author>
        <name>Tully, Jeffrey L</name>
      </author>
      <author>
        <name>Curran, Brian P</name>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
    </item>
    <item>
      <title>Outcomes Following Distal Nerve Blocks for Open Carpal Tunnel Release: A Single-Institution Retrospective Study</title>
      <link>https://escholarship.org/uc/item/4kx0697f</link>
      <description>Background Severe cases of carpal tunnel syndrome (CTS) are treated with surgical decompression, for which regional nerve blocks are often administered. There is little data about complications associated with these regional techniques for this surgery. The primary objective was to assess the association of ultrasound-guided regional anesthesia nerve blocks in patients undergoing carpal tunnel release with symptom resolution. Methods This single-institution, retrospective study analyzed all patients undergoing open carpal tunnel release&amp;nbsp;from March 2018 to November 2020. Primary exposure was either regional anesthesia (median and ulnar nerve blocks) or non-regional anesthesia (general anesthesia or local infiltration by surgeon). The primary outcome measurement was symptom resolution at postoperative follow-up at 30-60 days. Secondary outcomes were postoperative surgical site infection, time in operating room (minutes), and post-anesthesia care unit (PACU) length of stay (min).&amp;nbsp;The...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4kx0697f</guid>
      <pubDate>Fri, 2 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Tsuda, Paige S</name>
      </author>
      <author>
        <name>Du, Austin L</name>
        <uri>https://orcid.org/0000-0003-0313-0153</uri>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Curran, Brian P</name>
      </author>
    </item>
    <item>
      <title>The Association of Primary Anesthesia Type With Postoperative Transfusion in Anemic Patients Undergoing Primary Total Joint Arthroplasty</title>
      <link>https://escholarship.org/uc/item/1xc0q0fs</link>
      <description>Background and objective A high rate of preoperative anemia has been observed in patients undergoing knee and hip arthroplasty. The type of anesthesia that patients receive may play a role in preventing or minimizing adverse outcomes in these patients. In this study, we aimed to examine the complication rates in patients with severe anemia undergoing this surgery. In addition, we explore whether neuraxial anesthesia is associated with better outcomes compared to general anesthesia. Methods The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) registry was used to extract data related to patients who underwent total hip or knee arthroplasty from 2014 to 2016. Only those patients with a hematocrit level &amp;lt;30% were included, and they were classified into two groups based on primary anesthesia type received: neuraxial versus general anesthesia. The primary outcome of interest was postoperative transfusion. Secondary outcomes included 30-day hospital...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1xc0q0fs</guid>
      <pubDate>Fri, 2 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Kim, Joseph</name>
      </author>
      <author>
        <name>Curran, Brian P</name>
      </author>
      <author>
        <name>Du, Austin L</name>
        <uri>https://orcid.org/0000-0003-0313-0153</uri>
      </author>
      <author>
        <name>Gabriel, Rodney A</name>
      </author>
      <author>
        <name>Du, Austin</name>
      </author>
    </item>
    <item>
      <title>Cancer‐cell‐secreted extracellular vesicles target p53 to impair mitochondrial function in muscle</title>
      <link>https://escholarship.org/uc/item/2w7396m9</link>
      <description>Skeletal muscle loss and weakness are associated with bad prognosis and poorer quality of life in cancer patients. Tumor‐derived factors have been implicated in muscle dysregulation by inducing cachexia and apoptosis. Here, we show that extracellular vesicles secreted by breast cancer cells impair mitochondrial homeostasis and function in skeletal muscle, leading to decreased mitochondrial content and energy production and increased oxidative stress. Mechanistically, miR‐122‐5p in cancer‐cell‐secreted EVs is transferred to myocytes, where it targets the tumor suppressor TP53 to decrease the expression of TP53 target genes involved in mitochondrial regulation, including Tfam, Pgc‐1α, Sco2, and 16S rRNA. Restoration of Tp53 in muscle abolishes mitochondrial myopathology in mice carrying breast tumors and partially rescues their impaired running capacity without significantly affecting muscle mass. We conclude that extracellular vesicles from breast cancer cells mediate skeletal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2w7396m9</guid>
      <pubDate>Tue, 16 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ruan, Xianhui</name>
      </author>
      <author>
        <name>Cao, Minghui</name>
      </author>
      <author>
        <name>Yan, Wei</name>
      </author>
      <author>
        <name>Jones, Ying Z</name>
      </author>
      <author>
        <name>Gustafsson, Åsa B</name>
      </author>
      <author>
        <name>Patel, Hemal H</name>
        <uri>https://orcid.org/0000-0001-6722-9625</uri>
      </author>
      <author>
        <name>Schenk, Simon</name>
        <uri>https://orcid.org/0000-0002-8224-3203</uri>
      </author>
      <author>
        <name>Wang, Shizhen Emily</name>
        <uri>https://orcid.org/0000-0002-5036-8175</uri>
      </author>
    </item>
    <item>
      <title>Impact of stepwise hyperventilation on cerebral tissue oxygen saturation in anesthetized patients: a mechanistic study</title>
      <link>https://escholarship.org/uc/item/8sd3g0dd</link>
      <description>BACKGROUND: While the decrease in blood carbon dioxide (CO2 ) secondary to hyperventilation is generally accepted to play a major role in the decrease of cerebral tissue oxygen saturation (SctO2 ), it remains unclear if the associated systemic hemodynamic changes are also accountable.
METHODS: Twenty-six patients (American Society of Anesthesiologists I-II) undergoing nonneurosurgical procedures were anesthetized with either propofol-remifentanil (n = 13) or sevoflurane (n = 13). During a stable intraoperative period, ventilation was adjusted stepwise from hypoventilation to hyperventilation to achieve a progressive change in end-tidal CO2 (ETCO2 ) from 55 to 25 mmHg. Minute ventilation, SctO2 , ETCO2 , mean arterial pressure (MAP), and cardiac output (CO) were recorded.
RESULTS: Hyperventilation led to a SctO2 decrease from 78 ± 4% to 69 ± 5% (Δ = -9 ± 4%, P &amp;lt; 0.001) in the propofol-remifentanil group and from 81 ± 5% to 71 ± 7% (Δ = -10 ± 3%, P &amp;lt; 0.001) in the sevoflurane...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8sd3g0dd</guid>
      <pubDate>Mon, 17 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>ALEXANDER, BS</name>
        <uri>https://orcid.org/0000-0003-3657-0673</uri>
      </author>
      <author>
        <name>GELB, AW</name>
        <uri>https://orcid.org/0000-0001-7004-4410</uri>
      </author>
      <author>
        <name>MANTULIN, WW</name>
      </author>
      <author>
        <name>CERUSSI, AE</name>
      </author>
      <author>
        <name>TROMBERG, BJ</name>
        <uri>https://orcid.org/0000-0002-7481-7975</uri>
      </author>
      <author>
        <name>YU, Z</name>
        <uri>https://orcid.org/0000-0001-9700-1795</uri>
      </author>
      <author>
        <name>LEE, C</name>
      </author>
      <author>
        <name>MENG, L</name>
      </author>
    </item>
  </channel>
</rss>
